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Transcription of protein-coding genes in Saccharomyces cerevisiae is tightly 
regulated. Activators of transcription raise the local concentration of the TATA-
binding protein Tbp1p at their target promoters by stimulating the binding of Tbp1p 
to the respective TATA-box. TBP1 is an essential gene in S. cerevisiae and it plays a 
vital role in all three classes of transcription by RNA polymerase I, II and III. We 
made use of the TBP1(E186D) mutant to study the physiological roles of proteins 
interacting with Tbp1p. With the help of the Split-Ubiquitin assay, we found that the 
interactions of Tbp1p with TFIIB (Sua7p), Mediator (Srb4p/Med17p), RNA 
polymerase II (Rpb1p, Rpb4p, Rpb8p), and RNA polymerases I and III (Rpb8p) were 
affected by the TBP1(E186D) mutation. We performed suppressor screens with these 
five proteins and isolated SUA7(E202G) as an allele-specific suppressor of the 
temperature-sensitivity of S. cerevisiae cells carrying the TBP1(E186D) mutation. 
SUA7(E202G) also suppressed the gal- phenotype, slow-growth and 3-aminotriazole- 
sensitivity caused by the TBP1(E186D) mutation. The Split-Ubiquitin assay and GST-
pulldown experiments showed that the SUA7(E202G) mutation restored binding of 
TFIIB to Tbp1(E186D)p in vivo and in vitro. In addition, we observed that 
Tbp1(E186D)p was expressed at a lower level than wild-type Tbp1p, and that 
SUA7(E202G) restored the protein level of Tbp1(E186D)p. This suggested that the 
TBP1(E186D) mutation might have generated its phenotypes by making Tbp1p the 
limiting factor for activated transcription. DNA microarray analysis indicated that the 
TBP1(E186D) temperature-sensitivity and slow-growth phenotypes might have been 
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caused by insufficient amounts of Tbp1p for efficient transcription of the rRNA genes 
by RNA polymerase I. 
 
From the results mentioned above, the E186D mutation was assumed to have 
caused protein degradation of Tbp1p. It was thought that the proteolytic instability of 
Tbp1(E186D)p caused the gal- phenotype, 3-aminotriazole and temperature-
sensitivity of the E186D mutation. As Ubp3p was known to stabilize proteins and to 
co-purify with TFIID, we looked into the ability of Ubp3p to suppress the 
Tbp1(E186D)p phenotypes. We found that the over-expression of Ubp3p suppressed 
the various phenotypes of the TBP1(E186D) mutation. Importantly, the over-
expression of Ubp3p also stabilized Tbp1(E186D)p by increasing the protein half-life.  
 
Ubp3p plays an important role in the stabilization of wild-type Tbp1p as well, 
since UBP3-deleted yeast cells showed a significant reduction in protein stability of 
GST-Tbp1p. The deletion of UBP3 caused a gal- phenotype, and this coincided with 
the results from chromatin immunoprecipitation and real-time PCR experiments 
showing that Ubp3p was recruited to the GAL1 promoter upon galactose-induction 
and that deletion of UBP3 caused a reduction in GAL1 transcription. We also found 
Tbp1p to be polyubiquitinated, which further showed that Tbp1p might be a target of 
Ubp3p. Taken together, these results imply that Tbp1p could be deubiquitinated at the 
promoters during induction. This would stabilize Tbp1p and result in gene activation.    
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Activated transcription of protein-coding genes by RNA polymerase II in 
eukaryotic cells is a complicated process involving the orchestral interplay of various 
proteins  (Naar et al., 2001; Szutorisz et al., 2005; Woychik and Hampsey, 2002). For 
many years, tremendous efforts have been made to understand how gene expression is 
regulated. These efforts have led to the discovery of basal transcription factors, 
activators, repressors and many other transcription proteins. The cooperative effort 
and crosstalk between these transcription proteins are important for gene activation.  
 
The ordered recruitment of various activators and transcription factors drives 
gene transcription at the right timing and for the right length of time (Cosma, 2002). 
According to the recruitment model, activators of transcription are first stimulated to 
bind to the Upstream Activation Sequence (UAS) under inducing conditions (Bryant 
and Ptashne, 2003; Ptashne and Gann, 1997). The UAS is important in activated 
transcription as deletion of the UAS results in little or no transcription (Prelich and 
Winston, 1993). Activators work by raising the local concentration of limiting factors 
at the promoter in order for transcription to begin (Ptashne, 2005). Gal4p is an 
example of a well-studied activator in yeast (Traven et al., 2006). Gal4p binds to the 
UAS elements found in the GAL1-GAL10, GAL7 and GAL80 promoters. It recruits the 
transcription machinery and coactivators such as the Spt-Ada-Gcn5-Acetyltransferase 
complex (SAGA) and TATA-Binding Protein (Tbp1p) to initiation gene transcription 
from these promoters upon induction. The recruitment of SAGA to promoters acts as 
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a scaffold for the assembly of the preinitiation complex (Bhaumik and Green, 2001) 
and is needed for the recruitment of the mediator (Bhaumik et al., 2004). The histone 
acetyltransferase activity of chromatin remodeling complexes like SAGA also helps 
to facilitate transcription by acetylating histone tails resulting in the unwinding of 
DNA sequences packed by nucleosomes (Fukuda et al., 2006; He and Lehming, 2003). 
The tightly-coiled DNA sequences packed by nucleosomes into chromatin interfere 
with gene transcription (Boeger et al., 2005; Chodaparambil et al., 2006). In order for 
the transcription machinery to gain access to the basal promoter, the chromatin 
remodeling factors and histone modifying proteins are required to remodel the 
chromatin structure (Peterson, 2003; Peterson and Logie, 2000). The task to transcribe 
through nucleosomes continues to be a challenge for the elongating polymerase. Post-
translational modifications of histone tails allow for nucleosomes mobility, therefore 
enabling elongating polymerase to transcribe through the gene (Cosgrove et al., 2004; 
Felsenfeld et al., 2000). 
 
The activator bound to the UAS stimulates the recruitment of TFIID, including 
Tbp1p, to the TATA-box. The TATA-box is an AT-rich site located upstream of the 
transcription start site. It is approximately 40-120 bp away from the start site in yeast, 
while the distance is approximately 25-35 bp in higher eukaryotes. TBP1 was 
identified in a genetic selection for suppressors of a Ty insertion in the HIS4 promoter, 
and it plays an important role in gene regulation (Eisenmann et al., 1989; Hahn et al., 
1989; Yamaguchi et al., 2001). TBP1 is an essential gene and is one of the few 
transcription factors that are conserved across eukaryotes. Mutations in human Tbp1p 
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are found to be linked to neurological diseases (Reid et al., 2004; van Roon-Mom et 
al., 2005; van Roon-Mom et al., 2002). The binding of Tbp1p to the TATA-box is the 
hallmark of gene transcription, and the binding of Tbp1p is also important for TATA-
less promoters (Burke and Kadonaga, 1996; Klages and Strubin, 1995; Yoganathan et 
al., 1992).  
 
Tbp1p is a general transcription factor that is found in a variety of complexes in 
yeast such as SL1 (Selectively Factor), TFIID and TFIIIB, which are involved in gene 
regulation by the three classes of RNA polymerases (Pugh, 2000). The SL1 complex 
is required for the transcription of rRNA by RNA polymerase I (Friedrich et al., 2005; 
Gorski et al., 2007). TFIIIB is required for the transcription of tRNA and 5S rRNA by 
RNA polymerase III (Huet and Sentenac, 1992; Kassavetis and Geiduschek, 2006). 
Tbp1p, together with the 14 TBP1-associated factors (TAFs), forms TFIID, which is 
needed for the transcription of RNA polymerase II dependent promoters (Albright and 
Tjian, 2000; Sanders et al., 2002).   
 
Tbp1p functions as a co-activator, which is recruited by activators and binds 
directly to the minor groove of the TATA-box sequence to nucleate the assembly of 
the preinitiation complex (Hampsey, 2006; Tsai and Sigler, 2000). Mutations in 
Tbp1p that hinder its binding to the TATA-box cause the inability for transcription of 
regulated genes to begin. This hints at the importance of the recruitment of Tbp1p for 
transcription (Hampsey, 1998). Following the binding of TFIID, recruitment of other 
general transcription factors occurs in the order of TFIIA, TFIIB (Sua7p), TFIIF, 
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RNA polymerase, TFIIE and TFIIH (Lemon and Tjian, 2000).  
 
Each of the general transcription factors added onto the promoter has a different 
function. Briefly, TFIIA is a complex of two subunits, which is known to regulate 
Tbp1p by dislodging Tbp1p dimers, and by loading Tbp1p onto the TATA-box (Liu 
et al., 1999). Interaction of TFIIA with Tbp1p is mediated by the TAFs proteins in 
TFIID (Kraemer et al., 2001; Robinson et al., 2005). Sua7p is a 38 kDa general 
transcription factor, and it plays a key role in the initiation and start site selection by 
RNA polymerase II (Bangur et al., 1997; Chen and Hampsey, 2004; Faitar et al., 
2001). It autoacetylates itself in the presence of acetyl-CoA at K238, which is thought 
to stabilize its interaction with TFIIF and activate transcription (Choi et al., 2003). 
Sua7p is an essential component of the preinitiation complex and enters the complex 
after binding of Tbp1p to the TATA-box and before the recruitment of the RNA 
polymerase II takes place. TFIIF is a complex of three subunits. Its entry into the 
preinitiation complex helps in facilitating promoter melting (Coulombe and Burton, 
1999). It was also proposed to be important for start site selection along with Sua7p 
(Freire-Picos et al., 2005). TFIIE functioned closely with TFIIF as previous studies 
had shown that interspecies complementation was only possible if both TFIIE and 
TFIIF are from the same species (Li et al., 1994). TFIIE stimulates CTD kinase and 
ATPase activities of TFIIH. TFIIH was found to possess these enzyme activities: 
DNA-dependent ATPase, ATP-dependent helicase and CTD kinase. These enzymatic 
activities are important in promoting promoter clearance and activation of elongation 
for transcription to begin (Guzman and Lis, 1999; Nair et al., 2005). Once the 
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preinitiation complex is formed at the site of the promoter, transcription begins with 
the phosphorylation of the C-terminus of RNA polymerase II and promoter clearance 
(Martinez, 2002).  
 
The recruitment model described above is not the only proposed model that 
describes how transcription activation occurs in eukaryotic cells. Another version of 
gene activation is the reverse recruitment model (Sarma et al., 2007). According to the 
reverse recruitment hypothesis, transcription factors form gene expression machines 
in the nuclear periphery, while uninduced genes are located in the center of the 
nucleus. Upon recruitment of a gene to a machine associated with a nuclear pore, the 
gene is transcribed, and the mRNA is exported out of the nucleus (Santangelo, 2006). 
This model was proposed to explain the Rap1p/Gcr1p (Repressor Activator Protein/ 
GlyColysis regulation) activation mechanism in yeast. This is of great importance 
because Rap1p/Gcr1p activation accounts for more than 75 % of the mRNA generated 
in yeast (Barbara et al., 2007). The activation mechanism of Rap1p/Gcr1p complies 
with the reverse recruitment model and many of the glucose-gene responsive 
regulators were found to function at the nuclear peripheral membrane (Menon et al., 
2005; Sarma et al., 2007). Researches have shown that many transcriptionally active 
genes, such as yeast INO3 and GAL1 were recruited to the nucleopore complex, while 
repressed genes remained in the nucleoplasm (Brickner and Walter, 2004; Casolari et 
al., 2004). The attachment of INO3 and GAL1 genes to nuclear periphery caused rapid 
accumulation of the INO3 and GAL1 mRNA. Upon repression, recently activated 
INO3 and GAL1 genes do not return to nucleoplasm, but remain attached to the 
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nuclear periphery (Brickner et al., 2007). The localization of repressed genes at 
nuclear periphery was mediated by histone variant H2A.Z, representing an epigenetic 
state that conferred transcriptional memory and this served to facilitate reactivation 
(Brickner et al., 2007).  
 
The ubiquitin-proteasome system was thought to play a role in transcription 
regulation (Dhananjayan et al., 2005). Histone H2B was the first protein known to be 
ubiquitinated, and publications had shown that the monoubiquitination of histone 
H2B could influences other histone modifications such as acetylation and methylation, 
which helps in regulating transcription (Briggs et al., 2002; Ricci et al., 2002; 
Shilatifard, 2006). The ubiquitin-proteasome system could regulate transcription by 
controlling activator location, controlling activator function and controlling activator 
levels (Muratani and Tansey, 2003). Recently, it was proposed that transcription 
factors may be subjected to two modes of ubiquitin regulation: One that is 
independent of transcription, which helps to regulate the protein levels in cells, and 
one that is dependent on transcription, which is needed for gene activation. Gal4p was 
found to be regulated under such a scenario. In glucose-repression, Gal4p is 
ubiquitinated and degraded via Grr1p (Glucose-Repression-Resistant) (Muratani et al., 
2005). During galactose-induction, Gal4p is ubiquitinated and degraded upon 
phosphorylation of S699 on RNA polymerase II via Dsg1/Mdm30 (Mitochondrial 
Distribution and Morphology) to initiate elongation (Muratani et al., 2005). The 
former mechanism is believed to restrict the Gal4p protein levels during glucose-
repression, while the latter mechanism is believed to recycle exhausted Gal4p during 
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galactose-induction.      
 
In this thesis, the interactions between Tbp1p and other transcription factors were 
studied using the Split-Ubiquitin assay (Johnsson and Varshavsky, 1994). The Split-
Ubiquitin assay has previously been used to detect interactions between nuclear 
proteins (Laser et al., 2000) and between integral membrane proteins (Stagljar et al., 
1998; Wachek et al., 2006). This method is based on the ability to split ubiquitin into 
two halves, namely the Nub and the Cub (N-terminal and C-terminal half of ubiquitin, 
respectively), which can be reconstituted into a native-like ubiquitin moiety if two 
proteins fused to these two halves interact inside the living cell. This brings about the 
N-end rule degradation of the reporter gene, ornithine decarboxylase (Ura3), which 
had been modified to start with an arginine residue (RUra3) and was linked to the C-
terminus of the Cub. The protein interaction between the two proteins fused to Nub and 
Cub, respectively, results in the cells being uracil auxotroph and FOA resistant 
(Lehming, 2002). This thesis started with a TBP1 mutant, which has a point mutation 
at the amino acid position 186, changing glutamic acid to aspartic acid. TBP1(E186D) 
has previously been described for its inability to support galactose-induced GAL1 
transcription (Virbasius et al., 2001). Yeast cells carrying the TBP1(E186D) mutation 
not only displayed a gal- phenotype but also grew slowly and showed sensitivity 
towards 3-aminotriazole and high temperature. We hope to gain a better 
understanding into the interaction between Tbp1p and other transcription proteins by 
using Tbp1(E186D)p to look for suppressors of the phenotypes caused by the 
TBP1(E186D) mutation.  
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2 SURVEY OF LITERATURE 
2.1 Catabolite Repression 
Saccharomyces cerevisiae favors the catabolism of glucose. Glucose is known 
as the preferred carbon source for yeast, and in its presence, utilization of other sugars 
for metabolism is completely abolished (Reece et al., 2006; Reece and Platt, 1997). 
This phenomenon is known as “catabolite repression” or “glucose-repression” (Entian 
and Zimmermann, 1982; Gancedo, 1992, 1998). If glucose is made available to yeast, 
the transcription of enzymes required to break down other carbon sources is repressed.  
The main effect of glucose is exerted at transcription level by interfering with the 
action of activators or by facilitating the effect of repressors. 
 
Gal4p is one of the well-studied activators in yeast whose activity is strongly 
regulated by the presence of glucose (Parthun and Jaehning, 1990; Traven et al., 
2006). Gal4p is responsible for the transcription of the GAL gene family, including 
GAL1, GAL2, GAL7, and GAL10. These structural genes are required for transporting 
galactose into cell, and its metabolism through the glycolytic pathway. Gal4p binds 
DNA as a dimer (Xu et al., 1995). Ga14p has a DNA-binding domain at the 
N-terminus, and an activation domain at the C-terminus (Marmorstein et al., 1992). 
Gal4p activates the GAL genes by binding to the Upstream Activating Sequence of 
the GAL genes (UASGAL) via its DNA-binding domain. GAL1-10 share four UASGAL 
and they are divergently transcribed. The UASGAL can be found in all the genes 
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known to be inducible by galactose. In the presence of glucose, Gal4p binds to the 
UASGAL via its DNA-binding domain. However, there are no detectable transcripts of 
the structural GAL genes. This shows that activator binding alone is not sufficient for 
the expression of GAL1-10. The UASGAL element was found to be in a nucleosome-
free state regardless of the carbon source (Lohr, 1997). This is in contrast to the 
nucleosomes at the TATA-box and the transcription start site, which are displaced 
after galactose-induction (Bash and Lohr, 2001). Hence, the structural GAL genes of 
cells in glucose are poised for expression, but they are still completely inactive. The 
localization of Gal4p to the UASGAL in cells grown under non-inducible conditions 
could accelerate the transcription of these genes upon activation (Bash and Lohr, 
2001). Phosphorylation of Gal4p at multiple serine sites has been reported at both the 
N- and C-terminal residues of Gal4p (Sadowski et al., 1996). P-Gal4p has been found 
to be associated to its ability to bind to DNA and for stimulating transcription in vivo 
(Rohde et al., 2000; Sadowski et al., 1996). The association of transcriptionally active 
P-Gal4p with Gal80p was also observed (Parthun and Jaehning, 1992). This supported 
the hypothesis that Gal80p need not be disassociated from Gal4p upon galactose 
induction. Most of these modifications are mediated by Srb10p/Srb11p, the cyclin-
dependent kinase of RNA polymerase II holoenzyme (Sadowski et al., 1996; 
Sadowski et al., 1991). Phosphorylation of Gal4p at S699 by Srb10p/Srb11p was 
shown to be sufficient for galactose-mediated activation of the GAL genes (Rohde et 
al., 2000).   
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The lack of transcriptional activation of the GAL genes despite the binding of 
Gal4p at the UASGAL element is due to the binding of Gal80p to Gal4p. Gal80p has 
two binding partners: Gal4p and Gal3p. Gal80p masks the activation domain of 
Gal4p bound at the UASGAL site, preventing the activation of the GAL genes by 
Gal4p (Pilauri et al., 2005). In addition, Gal80p mediates the deposition of 
nucleosomes at the promoter region of GAL1-10, thereby conferring an inactive state 
upon GAL1-10 (Bash and Lohr, 2001). Gal3p is another regulatory protein that plays 
an important role in the transcription of the GAL genes. It is not known how the 
galactose-triggered binding of Gal3p to Gal80p relieves the inhibition of Gal4p by 
Gal80p. The regulatory proteins are not localized in the same compartment in cells. 
Gal4p is found in the nucleus and Gal3p resides in the cytoplasm, while Gal80p can 
shuttle between cytoplasm to nucleus (Peng and Hopper, 2000). One prevailing 
model suggested regulation of the GAL genes via nucleo-cytoplasmic shuttling - the 
presence of galactose triggered the protein-protein interaction of Gal3p with Gal80p 
in the cytoplasm, reducing the concentration of Gal80p in the nucleus. This caused a 
reduction in the binding of Gal80p to Gal4p, resulting in the activation of the GAL 
genes (Peng and Hopper, 2002; Ruhela et al., 2004). Contrary to this hypothesis, 
other articles have supported the idea that Gal80p does not dissociate from Gal4p 
during the activation of the GAL genes (Bhaumik et al., 2004; Leuther and Johnston, 
1992). Gal3p, which resides in the cytoplasm, has to move across the nuclear 
membrane in order to bind Gal80p. The binding of Gal3p to Gal80p causes a change 
in configuration of Gal80p, therefore releasing the activating domain of Gal4p in the 
presence of ATP (Platt and Reece, 1998; Sil et al., 1999). This theory, however, does 
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not fully explain how activation of the GAL genes can still occur when Gal3p is 
tethered to membranes outside the nucleus. Hence, the existence of the Gal3p-Gal4p-
Gal80p complex remains controversial.   
 
Repression of the GAL genes in glucose is regulated via Mig1p (Multicopy 
Inhibitor of GAL gene expression). Mig1p is a C2H2 zinc finger protein that binds to 
the promoters of genes that are repressed by glucose such as the GAL genes (Frolova 
et al., 1999; Nehlin et al., 1991; Ostergaard et al., 2001). Mig1p resides in the 
cytoplasm, and it is translocated into the nucleus in the presence of glucose. This is 
made possible by the phosphorylation of Mig1p by the Snf1p (Sucrose non-
fermenting) kinase complex (De Vit et al., 1997; Treitel et al., 1998). Once inside the 
nucleus, P-Mig1p exerts its repressive effect by recruiting the Cyc8p-Tup1p 
corepressor complex to its target promoters, which include a wide variety of genes 
(Papamichos-Chronakis et al., 2004). Once glucose starvation occurs, P-Mig1p is 
dephosphorylated by the Reg1p-Glc7p phosphatase complex. Dephosphorylated 
Mig1p is exported out of the nucleus, resulting in the derepression of the Mig1p target 
genes (Nehlin et al., 1991; Ostergaard et al., 2001; Verma et al., 2005). 
 
2.2 Ubiquitination and the Control of Transcription 
Activators of regulated genes are usually kept in an inactive form and they 
become active in response to stimulating conditions. These conditions might trigger 
post-translational modifications of the activator or disrupt the interaction between the 
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activator and its inhibitor, thereby allowing the activator to increase transcription of 
its target genes. To regulate the duration of gene activation, activators are thought to 
be degraded at the promoter. This is supported by the finding that transcriptional 
activation domains overlap with proteolytic signals (degrons) found in some 
activators (Molinari et al., 1999; Salghetti et al., 1999). The ability of the 
transcriptional activation domain to mediate proteolysis by ubiquitination suggested a 
link between ubiquitination and transcription (Salghetti et al., 2000).  
 
The tagging of ubiquitin molecules onto proteins modulates the stability of 
various proteins. Polyubiquitinated proteins are targeted for degradation by 26S 
proteasome, which is composed of the 19S regulatory subcomplex and the 20S 
proteolytic subcomplex. The attachment of ubiquitin to proteins does not necessarily 
target them for destruction. The ubiquitination of proteins seems to be involved in 
proteasome-independent functions such as endocytosis, localization of proteins to 
nucleus or signal transduction (Depraetere, 2001; Pickart, 2001). In the recent years, 
the activation of the GAL1 gene was found to trigger the association of the 19S 
ATPases with the GAL1 promoter. This association was established by the interaction 
between Gal4p and the two ATPases, Sug1p and Sug2p (Gonzalez et al., 2002).  This 
showed that the 19S subcomplex functioned in a non-proteolytic manner in RNA 
polymerase II transcription (Collins and Tansey, 2006; Gonzalez et al., 2002; Ottosen 
et al., 2002). The 20S subcomplex was thought to dissociate from the activation 
domain and was not involved in the binding to the promoter (Ferdous et al., 2007; 
Gonzalez et al., 2002). This is in contrast to findings by other groups, who found the 
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association of 20S proteasome to the activator domain as well (Lee et al., 2005; 
Morris et al., 2003).     
 
The new paradigm proposed that transcription factors may have two modes of 
ubiquitin regulation: One that is independent of transcription, which helps to regulate 
the protein in cells and another one that is dependent on transcription, which is needed 
for gene activation. Gal4p was found to be regulated under such scenarios. In glucose- 
repression, Gal4p is ubiquitinated and degraded via Grr1p (Glucose-Repression-
Resistant) (Muratani et al., 2005). During galactose-induction, Gal4p is ubiquitinated 
and degraded upon phosphorylation of S699 on RNA polymerase II via Dsg1/Mdm30 
(Mitochondrial Distribution and Morphology) to initiate elongation (Muratani et al., 
2005). The degradation of Gal4p under conditions of glucose-repression is believed to 
limit the amount of Gal4p in the nucleus. The degradation of Gal4p under conditions 
of galactose-induction is believed to recycle exhausted Gal4p and to allow new Gal4p 
to enter the enhancer. This concept was later challenged by Kodadek’s group, where 
they showed that during induction, Gal4p was stable, and inhibition of the 
proteasomic pathway did not affect Gal4p-mediated gene transcription (Nalley et al., 
2006).          
 
Over the years, it has become clear that the ubiquitination of proteins plays an 
important role in the regulation of various cellular processes such as DNA repair, cell 
cycle control, protein degradation, gene transcription and endocytosis (Hanna and 
Finley, 2007; Muratani and Tansey, 2003; O'Connell and Harper, 2007). In contrast, 
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very little information is available on deubiquitinating enzymes, which is believed to 
also play an equally important role as their counterparts (Wing, 2003).  
 
The attachment of multiple ubiquitin molecules as a K48-linked polyubiquitin 
chain results in the degradation of the target protein (Hochstrasser, 2004). The 
reversal is catalysed by deubiquitinating enzymes, which helps to increase the 
proteolytic stability of the respective targeted protein (Kim et al., 2003). 
Deubiquitinating enzymes can be classified into two main subfamilies based on their 
sequence homology and mechanisms: The ubiquitin-specific processing protease 
group (UBP) and the ubiquitin carboxyl-terminal hydrolases group (UCH) (Wilkinson, 
1997). The largest and most diverse group among deubiquitinating enzymes is that of 
the UBP familiy. The UBPs has little homology besides the catalytic core domain 
(Amerik and Hochstrasser, 2004). The UBPs varies in the presence of N-terminal 
extension, C-terminal extension or insertions in catalytic domain. Although the 
functionality of these domains is not clear, many publications had suggested that these 
domains might be involved in subcellular localization, substrate recognition and co-
factors association (Wing, 2003). There are altogether 16 UBPs (UBP1-16) and only 1 
UCH (YUH1 Yeast Ubiquitin Hydrolase) in yeast (Amerik et al., 2000). More 
deubiquitinating enzymes are found in higher eukaryotes. UBPs are conserved across 
various species hinting on their importance in regulating cellular processes. The 
substrate specificity of each UBP is not fully known. However, in the recent years, 
substrates of some of the UBP enzymes were reported. Ubp8p was found to be a 
component of the SAGA complex, which is a chromatin remodeling complex. Upon 
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the binding of SAGA to histone, Ubp8p was found to deubiquitinated H2B K123, 
thereby altering the status of H3K4 and K36 methylation and regulating transcription 
(Henry et al., 2003).  
 
UBP3 is the yeast homologue of USP10 in human cell. It is of interests in this 
thesis as it was found to be a component of TFIID, which also carries Tbp1p (Auty et 
al., 2004). This hints that Ubp3p has a role to play in the transcription of genes. 
Ubp3p requires the binding of co-factor Bre5p (Brefeldin A sensitivity), which 
interacts with Ubp3p via its NTF2 domain (Nuclear Transfer Factor 2) (Li et al., 
2005). The binding of Bre5p to Ubp3p is required for the functionality of Ubp3p 
(Cohen et al., 2003; Li et al., 2007). The Ubp3p seems to play diverse roles in cells. It 
has been reported to be important for the deubiquitination of Sec23p (Secretory 
protein). This functions to maintain an efficient secretion pathway in cells (Cohen et 
al., 2003). Ubp3p was hypothesized to regulate transcriptional silencing through its 
binding with Sir4p (Slient Information Regulator), thereby inhibiting transcriptional 
silencing (Moazed and Johnson, 1996). Ubp3p has also been implicated in cellular 
response to DNA damage (Bilsland et al., 2007). In addition, Ubp3p has the ability to 
stabilize proteins. The deubiquitinating activity of Ubp3p is thought to give misfolded 
proteins a chance to refold (Brew and Huffaker, 2002). Recently, Ubp3p has also been 
reported to negatively regulate the protein level of Pkc1p (Protein Kinase C), resulting 
in the down-regulation of Pkc1-mediated signaling pathway that controls cell wall 
integrity in yeast (Wang et al., 2008). Taken together, these findings indicate the 
importance of deubiquitinating enzymes not only in transcription, but also in other 
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vital cellular events.     
 
2.3 Amino Acid Control 
2.3.1 Translational Regulation of GCN4 
Gcn4p (General control nonderepressible) is a transcriptional activator of the 
amino acid biosynthetic genes, and it is also capable of stimulating the expression of 
aminoacyl-tRNA-synthenase. The expression of Gcn4p in amino-acid starved cells is 
tightly regulated, and it occurs at the transcriptional level, at the translational level 
and at the level of protein stability (Hinnebusch and Natarajan, 2002). Amino acid 
starvation causes a two-fold increase in GCN4 mRNA level (Albrecht et al., 1998). 
Gcn4p protein has a short half-life of less than 5 minutes in cells grown under amino 
acid-rich conditions. Phosphorylation of Gcn4p by Pho85p and Srb10p leads to its 
ubiquitination by the SCFCDC4 E3 ubiquitin ligase and the subsequent degradation by 
the 26S proteasome (Meimoun et al., 2000). Amino acid starvation inhibits Pho85p, 
resulting in an increased half-life of Gcn4p protein. The mediator component Srb10p 
remains active and is believed to limit the number of transcription rounds triggered by 
Gcn4p (Chi et al., 2001). The translational control of GCN4 is unique and will be 
described in detail here. According to the current model, the translation of GCN4 
mRNA begins with the binding of Met-tRNAi Met to the tertiary complex (TC), which 
also contain eukaryotic initiation factor 2 (eIF2) charged with guanine tri-phosphate 
(GTP) by the enzymatic effect of guanine nucleotide exchange factor GEF eIF2B. 
The addition of Met-tRNAi Met to charged TC gives rise to the 43S ribosome. The 
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binding of 43S to the 5' GCN4 mRNA forms the 48S ribosome, which will scan the 
mRNA for AUG codon for translation initiation. On base pairing of Met-tRNAi Met 
with the AUG codon, the bound GTP is hydrolyzed to release eIF2-GDP. The 
recharging of GDP to GTP is an important regulation step in translational control. 
There are four upstream open reading frames (uORFs) before the AUG codon of 
GCN4 is encountered by the ribosome. These uORFs are translational barriers which 
prevent unnecessary translation of Gcn4p. Hence, the removal of all four uORFs 
causes constitutive translation of Gcn4p (Mueller and Hinnebusch, 1986).  
 
In the case of amino acid starvation, the ribosome will scan uORF1 and bypass 
uORF2, 3, and 4. The ribosome will reinitiate at the AUG of the GCN4 mRNA, 
causing a 2 to 10-fold increase in Gcn4p protein level, depending upon the strain 
background (Hinnebusch and Natarajan, 2002). Bypassing is not possible when amino 
acids are in abundance, because of the presence of a large amount of charged TC. The 
presence of charged TC is a regulation effect of Gcn2p. Gcn2p phosphorylates eIF2 at 
serine residue 51 when cells experience amino acid starvation, thereby inhibiting the 
effect of eIF2B. At low concentration of TC, less 48S ribosome scanning downstream 
of uORF1 would rebind with TC before reaching uORF2, 3 or 4. Therefore, the 
chances of ribosome reinitiating at ORF of GCN4 mRNA bypassing the other uORFs 
is higher, resulting in the increase of the translation rate of GCN4. It is conceivable 
that the distance between uORF1 and uORF4 is important for the regulation. If the 
distance between these two elements is increased, induction rate would decrease since 
now the ribosome has more time to rebind with charged TC before reaching uORF4 
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Figure 2.1 Schematic diagram of GCN4 mRNA and the position of uORFs.  The 
48S ribosome scans the mRNA and binds to the start codon at uORF1. If amino acid 
starvation occurs, approximately 50% of the initiated ribosome will bypass uORF2, 3 
and 4 before rebinding TC at the start codon of the GCN4 mRNA due to the lack of 
charged TC. This allows translational regulation of the GCN4 mRNA. 
 
2.3.2 Regulation of Gcn2p 
Gcn2p is a protein kinase which phosphorylates the α-subunit of eIF2. 
Phosphorylation of eIF2 by Gcn2p causes the decrease in charged TC, which in turn 
regulates the translation of GCN4 mRNA. Gcn2p is regulated by the presence of 
uncharged tRNA. Amino acid starved cells accumulate uncharged tRNA, which 
stimulated the kinase activity of Gcn2p. Gcn2p binds to different tRNA with different 
affinities but has lower affinities to charged tRNA. Hence, it is commonly believed 
that the binding of uncharged tRNA to Gcn4p activates Gcn2p kinase activity 
Translation of GCN4 
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Gcn2p has a C-terminal protein kinase domain and a histidyl-tRNA synthetase 
domain (HisRS) towards the N-terminus of the protein kinase domain. The HisRS 
domain is believed to bind uncharged tRNA to Gcn2p, and this induces a 
conformational change in Gcn2p stimulating its protein kinase activity. This 
eventually leads to phosphorylation of eIF2 on Ser 51, resulting in the inability of 
GEF eIF2B to catalyze the addition of GTP to eIF2 (Dever and Hinnebusch, 2005).  
  
2.4 Chromatin Modifications 
In eukaryotic cells, DNA is packed into nucleosomes by histones (Loden and 
van Steensel, 2005). The nucleosomes are then packed on top of one another into 
tightly-coiled chromatin. The condensed structure of chromatin is considered a 
general constraint on activities that required DNA accessibility such as DNA 
transcription, replication, recombination and repair. Therefore, the transient relief 
from such tension is necessary for proteins to gain accessibility to DNA sequences. 
The sequential changes of chromatin structure is achieved by post-translational 
modifications of the histone tails and by the activity of ATP-dependent chromatin 
remodeling complexes (Morales et al., 2001).  
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2.4.1 Covalent Histone Modification  
Post-translational modifications of histones include acetylation, methylation, 
phosphorylation, ubiquitination and sumoylation (Sumoylation is a post-translational 
modification involving the addition of SUMO – Small Ubiquitin Modifier proteins 
onto targeted proteins) (Khan and Krishnamurthy, 2005). There are two models for 
the functionality of these modifications. One is that these markings serve to 
decondense the tightly packed chromatin. In this way, the DNA sequences are made 
available to the transcription machinery. The other model argues that the 
modifications of histones attract chromatin binding proteins (Berger, 2002).  
 
Most, if not all of these post-translational modifications are reversible by 
specialized enzymes. Lysine is the key residue to histone modification. For example, 
methyltransferases (SET proteins) and demethylases (LSD1/BHC110 class and 
jumonji class) could add or remove methyl group from histone residues (Christensen 
et al., 2007; Shi et al., 2004; Tsukada et al., 2006). Acetylation is mediated by histone 
acetyltransferases (HATs) while the reverse is due to the activity of their counterparts, 
histone deacetyltransferases (HDACs) (Wade and Wolffe, 1997). Complexes in yeast 
carrying HAT activity include ADA (Ada histone acetyltransferase complex 
component), SAGA (Spt, Ada, Gcn5, Acetyltransferase), NuA3, NuA4, and TFIID 
(Lee and Young, 2000). HDAC is also found in multi-protein complexes such as Sin3 
and NuRD. Acetylation of lysine residues reduces the positive charge of histones, 
resulting in less condensed chromatin. Hence, acetyltransferases are generally 
associated with coactivators of transcription, while deacetylases are generally 
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associated with transcriptional corepressors. 
 
Histones were found to be modified at their N-terminal tails, which are 
protruding from the core and are accessible by proteins (Table 2.1). Many residues of 
histone N-terminal tails have been identified to undergo modifications. In 2002, the 
histone core of H3 was also found to be methylated by Dot1p (Disruption Of 
Telomeric silencing) (Ng et al., 2002; van Leeuwen et al., 2002). The methylation of 
H3K79 provides insights into the derepression of silent regions for the resetting of 
euchromatic regions. 
 
The histone code hypothesis proposed that single or combinatorial effects of 
specific histone tail modifications could serve as a barcode to direct certain cellular 
activities (Jenuwein and Allis, 2001; Strahl and Allis, 2000). Researchers hoped to 
decipher this code so as to study how they can influence cell fate. Nevertheless, the 
various observations made in histone modifications over the years cannot be related to 
activation transcription easily (Cosgrove and Wolberger, 2005). While acetylation 
seems to be associated with transcription, methylation can be involved in both 
transcription and repression depending on the residue that is being methylated (Xu et 
al., 2005). The differences in mono-, di-, trimethylation further complicate the 
outcome of these modifications. On the other hand, ubiquitination and sumoylation of 
residues remain much less predictable (Berger, 2007; Bulger, 2005; Cosgrove and 
Wolberger, 2005; Nathan et al., 2006).      
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Table 2.1 Histone modifications on the various amino acid residues. 
 Acetylation Methylation Phosphorylation Ubiquitination Sumoylation 
H2A K7; K21 Not reported S121; S128 K119 K126 






R23   
S10; S28; T3 Not reported Not reported 
H4 K5;K8; 
K13; K16 
R3 S1 Not reported Not reported 
 
2.4.2 Noncovalent Histone Modifications: Chromatin Remodeling 
Proteins  
Besides conforming to covalent histone tail modifications, chromatin is also 
subjected to remodeling, which involves removal or mobilization of nucleosomes at 
the DNA template. One of the well-studied coactivators involved in remodeling 
chromatin is the SWI/SNF complex (Chandy et al., 2006; Quinn et al., 1996). In yeast, 
this complex is not essential for viability. Human SWI/SNF was identified, and it has 
the same function as its yeast counterpart (Kwon et al., 1994). SWI/SNF disrupts 
chromatin in an ATP-dependent manner, and this step is important for transcription 
(Adkins et al., 2007; Yang et al., 2007). The disruptions of nucleosomes in chromatin 
was found to help in the binding of Tbp1p to the TATA-box, and it also makes DNA 
more accessible to other transcription factors (Imbalzano et al., 1994). Other ATP-
dependent chromatin remodeling complexes identified include ISWI and the Mi-2 
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complex (Mellor, 2006).  
 
2.5 Step-wise Recruitment Model 
Transcription of protein-coding genes in Saccharomyces cerevisiae is tightly 
regulated, and it involves the concerted actions of activators or repressors, general 
transcription factors, RNA polymerase II, and coactivators (Green, 2005).  
 
The recruitment model describes how activators work by bringing the 
transcription machinery to DNA (Keaveney and Struhl, 1998; Roeder, 1996). In other 
words, they promote the assembling of the preinitiation complex at the gene promoter. 
Activators are sequence-specific DNA-binding proteins. They have a DNA-binding 
domain (DBD) and a separable activating domain (AD). Activators facilitate 
transcription by initiating the recruitment of limiting factors at the promoter. The 
raising of the local concentrations of these limiting factors at the promoter brings 
about the recruitment of other transcription factors, hence resulting in the assembly of 
the preinitiation complex. One of these limiting factors is TATA-Binding Protein 
(Tbp1p) (Klein and Struhl, 1994; Kuras and Struhl, 1999; Xiao et al., 1995).  
 
The assembly of the preinitiation complex at the promoter is a pre-requisite for 
transcription initiation of all protein-coding genes in eukaryotic cells. There have been 
studies, which showed that the formation of the preinitiation complex involves step-
wise recruitment of various general transcription factors and RNA polymerase II 
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(Stargell and Struhl, 1996). Typically, the activator protein recruits Tbp1p, which is a 
subunit of the TFIID. Tbp1p binds first to the promoter at the TATA-box sequence. 
This in turn serves as a platform for the binding of TFIIA, TFIIB, TFIIF, RNA 
polymerase II, TFIIE and TFIIH (Figure 2.2). The recruitment of coactivators into the 
preinitiation complex at a later stage helps to make the chromatin accessible to other 
proteins required for transcription by modifying and remodeling the tightly-coiled 
chromatin structure. Coactivators such as the SAGA complex modify histone residues 
to uncoil chromatin. Once the preinitiation complex is formed at the promoter, 
transcription can occur after promoter clearance. An alternative model proposed that 
recruitment occurs via the recruitment of the holoenzyme. Holoenzymes are variable 
in composition, and they consist of RNA polymerase II, Mediator and some General 
Transcription Factors (Hengartner et al., 1995; Lee and Young, 2000; Myers and 
Kornberg, 2000). This hypothesis bypasses the need to recruit each individual 
transcription protein one after another (Section 2.5.2). 
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Figure 2.2 The recruitment model. The recruitment of various transcription proteins 
at the GAL1 promoter upon activation by Gal4p. This results in the formation of the 
preinitiation complex.  
 
2.5.1 General Transcription Factors 
General Transcription Factors (GTFs) are proteins required for gene 
transcription. Each of these GTFs has a different function, which stabilizes the RNA 
polymerase II on the promoter or preinitiation complex so that transcription can occur. 
These proteins are also involved in DNA melting, transcription initiation and 
transcription elongation. 
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TFIIA is a complex of two essential proteins, named Toa1p and Toa2p in 
S. cerevisiae. TFIIA has many roles in transcription by RNA polymerase II. TFIIA is 
important in facilitating the binding of Tbp1p to DNA (Liu et al., 1999) and in the 
regulation of the dissociation of Tbp1p dimer to monomer (Section 2.5.1.3.1). The 
interaction between TFIIA to Tbp1p is believed to be mediated through the direct 
binding between Tao1p and Taf11p; disruption of this interaction caused failure of 
transcription in vivo (Kraemer et al., 2001). TFIIA also interacts with many activators. 
Similarly, TBP1 mutants that fail to interact with TFIIA are deficient in activation, 
emphasizing the importance of TFIIA in transcription (Ozer et al., 1998).          
 
2.5.1.2 TFIIB (SUA7) 
In S. cerevisiae, SUA7 is an essential gene and, it is homologous to human 
TFIIB (Pinto et al., 1992). Sua7p plays a pivotal role in the assembly of the 
preinitiation complex, and it is required for the recruitment of RNA polymerase II to 
promoters. Sua7p has a zinc ribbon at the N-terminus, a core domain at the C-
terminus and a B-finger in between the two domains. The zinc ribbon is important for 
the recruitment of RNA polymerase II and TFIIF while the core domain is required 
for interacting with TBP.DNA complex (Barberis et al., 1993; Buratowski and Zhou, 
1993; Tubon et al., 2004). Structural studies showed that the interaction between 
Sua7p and RNA polymerase II aid in positioning DNA for unwinding and 
transcription (Bushnell et al., 2004). Mutational studies at the B-finger that caused a 
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shift in start site selection resulting in a cold sensitive phenotype in yeast indicated the 
importance of Sua7p in start site selection (Chen and Hampsey, 2004). Previous 
publications have also shown that Sua7p is involved in the selection of the start site of 
transcription probably by setting the distance between the TATA-box and the start site 
(Faitar et al., 2001; Li et al., 1994; Pinto et al., 1994; Zhang et al., 2002).  
 
Sua7p binds upstream of the TATA-box via the BRE element (TFIIB-
recognition element), and it also interacts with DNA downstream of the TATA-box 
(Deng and Roberts, 2005; Tsai and Sigler, 2000). However, it is thought that Sua7p 
cannot simply be brought to the promoter by virtue of its capability to interact with 
DNA sequences, but it has to bind to RNA polymerase II in order to be added to the 
DNA template (Elsby et al., 2006). Such a model coincides with the idea of the 
existence of a holoenzyme and that activated transcription is not a step-wise 
recruitment of various transcription protein procedures. In addition, Sua7p 
autoacetylates itself at the lysine residue K238 (Choi et al., 2003). This signifies yet 
another mode of regulation of how Sua7p can facilitate transcription, because the 
acetylated Sua7p was demonstrated to be able to interact with TFIIF more rapidly, 
resulting in strong activation of transcription (Choi et al., 2003).   
 
2.5.1.3 TFIID/TATA-Binding Protein 
The TATA-binding protein, Tbp1p, binds to the TATA-box sequence in the 
promoter of genes. Tbp1p (SPT15 – SuPpressor of Ty) was first isolated as suppressor 
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of a Ty element insertion, and it is required for transcription in vivo (Eisenmann et al., 
1989; Hahn et al., 1989; Yamaguchi et al., 2001). During transcriptional activation, 
activators bind to the enhancer sequence in order to recruit Tbp1p to the promoter. 
Tbp1p has the ability to stimulate the recruitment of the rest of the general 
transcription factors, resulting in preinitiation complex formation, which is essential 
for gene transcription to occur. 
 
TBP1 is an essential gene in yeast, and it is not only needed for transcription 
by RNA polymerase II, but it also plays an essential role in transcription by RNA 
polymerases I and III (Cormack and Struhl, 1992; Pugh, 2000). The association of 
Tbp1p with different proteins is speculated to bring Tbp1p to the right promoter for 
transcription. Tbp1p associates with a variety of complexes and each of these 
complexes is specifically important a different class of transcription.  
 
SL1 TBP/TAFI complex (Selective Factor 1) functions exclusively for the 
transcription of ribosomal RNA (rRNA). Importantly, rRNA forms a central part of 
the ribosome, which is responsible for the translation of mRNA to protein. In general, 
rRNA genes exist as tandem repeats in eukaryotes, but not all of them are activated at 
the same time. UBF (Upstream Binding Factor) is known to activate the transcription 
of ribosomal protein (RP) genes by interacting with SL1, but this precludes formation 
of  preinitiation complex at the promoter (Jantzen et al., 1990; Panov et al., 2006). 
This demonstrated that Ubfp could play a role in stimulating the promoter escape of 
RNA polymerase I instead of initiating the assembly of preinitiation complex at the 
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promoter (Panov et al., 2006).   
 
Transcription of tRNA, 5S rRNA, and U6 snRNA genes by RNA 
polymerase III is facilitated by TFIIIB TBP/TAFIII complex. Tbp1p is found in the 
TFIIIB complex together with the TFIIIB-related factor, Brf1p (B-Related Factor), 
and Bdp1p (transcription factor TFIIIB subunit) (Kassavetis and Geiduschek, 2006). 
Most RNA polymerase III-transcribed genes do not have a TATA box, and accurate 
placement of TFIIIB is aided by TFIIIC. 
     
TFIID is dedicated to transcription by class II RNA polymerase. Tbp1p 
exists as a core subunit of the general transcription factor II D (TFIID) together with 
approximately 14 TATA-association factors (TAFs) (Figure 2.3). The binding of 
TAFs to a promoter has great importance as they facilitate transcriptional activation. 
For example, Taf145p is a histone acetyltransferase, which can help to unwind 
compact chromatin for access of transcription factors to the DNA (Lee and Young, 
2000; Tora, 2002; Walker et al., 1997).  Almost all TAF genes are essential, and their 
deletions are lethal to S. cerevisiae. This indicates the critical role of TAFs in cell 
survival and transcription. TAFs can moderate Tbp1p affinity and specificity for core 
promoters through selective interactions with promoter sequences or with other 
components of the transcription machinery (Burley and Roeder, 1996; Ruppert and 
Tjian, 1995; Verrijzer et al., 1994).  
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Figure 2.3 Illustration of yeast TFIID.  
 
Most DNA-binding proteins bind DNA via the major groove, where DNA is 
more accessible and binding is more sequence specific. Tbp1p, however, binds to the 
minor groove. Like most proteins that selectively bind to the minor groove of DNA, 
Tbp1p can bend DNA upon binding, which is thought to bridge the various proteins 
bound upstream of the TATA-box with those bound downstream of the TATA-box 
(Tolic-Norrelykke et al., 2006).   
 
Not all promoters in yeast contain the TATA-box consensus sequence 
TATAAA, which is normally found 25 to 30 base pairs upstream of the transcription 
start site. Some promoters are TATA-less. TATA-less promoters are abundant in the 
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Despite of not having TATA-box sequences at their promoters, these genes apparently 
still require the binding of Tbp1p for activation (Pugh and Tjian, 1991). It is believed 
that at TATA-less promoters, other factors stabilized Tbp1p binding (Basehoar et al., 
2004). This reduced the dependence of Tbp1p binding onto the TATA sequence, but 
not compromising on Tbp1p occupancy (Basehoar et al., 2004). 
2.5.1.3.1 Regulation of Tbp1p 
The negative regulation of gene expression is normally associated to the 
inaccessibility of the transcription factors to DNA sequences as the sequences are 
tighly-colied by histone proteins (He and Lehming, 2003). However, studies from 
various groups have shown that the loss of chromatin proteins has very little effects 
on the accessibility of the promoter (Chitikila et al., 2002; DeRisi et al., 1997; Wyrick 
et al., 1999). Since the promoter region is intrinsically accessible to nuclear proteins, 
additional negative regulation on the transcription complex assembly is needed (Mai 
et al., 2000). The regulation of Tbp1p is of great interest as Tbp1p is an important 
limiting factor for transcriptional activation. The interplay between different Tbp1p 
regulators is important for regulating Tbp1p binding to different promoters at 
different genes (Basehoar et al., 2004; Huisinga and Pugh, 2004, 2007). Regulation of 
Tbp1p occurs by its binding to another Tbp1p, NC2 (Negative Cofactor 2) and Mot1p 
(Modifier of Transcription) (Pugh, 2000).  
   
The initial regulation of transcription occurs with the binding of Tbp1p to 
DNA as this served as a platform for the nucleation of preinitiation complex. The 
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DNA-binding ability of Tbp1p resides in the conserved C-terminal domain. The 
crystal structure of Tbp1p showed that the C-terminal domains of two Tbp1p could 
crystallize to form a dimer (Burley and Roeder, 1996). Dimerization of Tbp1p is an 
auto-inhibitory mechanism to its ability to bind DNA (Jackson-Fisher et al., 1999; 
Kou and Pugh, 2004). When not binding to DNA, Tbp1p exists as dimers, and this 
also protects Tbp1p from degradation (Jackson-Fisher et al., 1999). Hence, the 
dissociation of dimer Tbp1p becomes the rate-limiting step in transcription initiation. 
The dissociation of dimeric Tbp1p/TFIID is mediated by the transcription factor 
TFIIA (Chitikila et al., 2002; Coleman et al., 1999).  Once the Tbp1p dimer is 
dissociated, it is added to a TATA-box by TFIIA (Section 2.5.1.1 and Figure 2.4).  
 
NC2 has been shown to bind to DNA-bound Tbp1p and it blocks the 
assembly of the preinitiation complex (Cang and Prelich, 2002; Goppelt and 
Meisterernst, 1996). A single-point mutation at amino acid position 182, changing 
phenylalanine to valine on Tbp1p was reported to be sufficient to abolish interaction 
with NC2 (Cang et al., 1999). NC2 is a heterodimer, which is made up of two proteins 
namely, Ncb2p (Negative Cofactor B) and Bur6p (Bypass UAS Requirement). It was 
first identified as a repressor of transcription because NC2 competitively inhibits the 
binding of TFIIA and TFIIB (Cang et al., 1999; Goppelt and Meisterernst, 1996). 
Over the years, researches on NC2 have also shown that NC has dual effects on 
transcription being able to repress or activate transcription through its binding to 
Tbp1p (Cang and Prelich, 2002).          
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Mot1p is essential for yeast viability and encodes for a 210 kDa ATPase 
(Davis et al., 1992). Regulation of Mot1p is executed through an energy requiring 
mechanism, which dissociates Tbp1p from the promoter so that dimerization of 
Tbp1p can occur (Auble et al., 1994; Chicca et al., 1998). It was reported that ATP 
hydrolysis caused a conformational change on either Tbp1p or its interaction with 
Mot1p, resulting in the disruption of the TBP.DNA complex (Darst et al., 2003). 
Similar to NC2, Mot1p has been thought to implicate in both activation and repression 




Figure 2.4 Dissociation of Tbp1p dimer by TFIIA (A). Binding of TFIIA helps the 
loading of Tbp1p/ TFIID onto the promoter.  
 
2.5.1.4 TFIIE 
In the step-wise recruitment model, TFIIE is being recruited after RNA 
polymerase II and before TFIIH. TFIIE is made up of two subunits encoded by TFA1 
(56kDa) and TFA2 (34kDa) respectively. It has a zinc binding finger, which can bind 
to DNA and it can be involved in the recruitment of TFIIH and promoter melting (Lee 
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In S. cerevisiae, TFIIF has three subunits. A large subunit encoded by TFG1 
(Transcription Factor G), a medium sized subunit by TFG2 and a small subunit by 
TAF14. Besides existing as a subunit in TFIIF, Taf14p is also found in various protein 
complexes including TFIID, INO80 (INOsitol requiring), SWI/SNF, RSC (Remodel 
the Structure of Chromatin) and NuA3 (histone H3 acetyltranferase complex) (Kabani 
et al., 2005). TFIIF has been shown to be involved in many cellular processes such as 
facilitating the wrapping of DNA under RNA polymerase II, promoting promoter 




This is a multi-protein complex consisting of many subunits.  These subunits 
have various functions including helicase, CTD kinase and excision repair. The 
helicase activity is important in promoter opening and the CTD kinase phosphorylates 
RNA polymerase II during transcription initiation and elongation (Nair et al., 2005). 
 
2.5.2 Yeast Mediator 
Evidence for the presence of the Mediator came from an observation termed 
“squelching” in yeast. It was previously shown that the over-expression of an 
activator in yeast interfered with the activation by another activator. This indicated 
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that activators competed for a common limited resource in the yeast system for 
activation to take place (Gill and Ptashne, 1988; Triezenberg et al., 1988). This 
limited resource was thought to be either one of the GTFs or RNA polymerase II, 
since activators had been shown to bind to these proteins. However, none of these 
proteins could relieve the squelching effect when they were provided in excess 
individually. The squelching effect was lifted only through the addition of crude 
preparation from yeast. Hence, the activity which relieved squelching was termed 
Mediator (Kelleher et al., 1990). In 1994, the Mediator was biochemically purified by 
Roger Kornberg’s group (Kim et al., 1994). Since then, Mediator has also been 
isolated from human cells and it was found to aid in stimulating transcriptional 
activation like yeast Mediator (Gu et al., 1999; Jiang et al., 1998; Malik and Roeder, 
2005; Naar et al., 1999).   
 
Mediator is a huge multi-protein complex of 1 MDa consisting of as many as 
20 polypeptides (Figure 2.5) (Malik and Roeder, 2000). In addition, one form of the 
Mediator was found to contain additional subunits (Srb8-11) that are involved in 
transcriptional repression. The RNA polymerase II holoenzyme was discovered by 
virtue of their association with Suppressor of RNA polymerase B proteins (Srb). It 
was discovered when attempts were made to purified Srb proteins, but led to the 
identified of a large complex, which consisted of RNA polymerase II and GTFs  
(Davis et al., 2002; Thompson et al., 1993). This and many other findings suggested 
the recruitment of a preformed transcription complex like the holoenzyme rather than 
a step-wise recruitment model for activation (Davis et al., 2002; Gaudreau et al., 
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1998). Over the years, several experiments proved otherwise, and showed that RNA 
polymerase II and Mediator do not exist in one complex. Through chromatin 
immunoprecipitation techniques, different groups were able to show that Mediator 
was recruited to activator binding sites after RNA polymerase II (Bhoite et al., 2001; 












Figure 2.5 The component of the yeast Mediator. The Rgr1 subcomplex in pink 
with the Gal11 module of the Rgr1 subcomplex in blue is dedicated to specialized 
activators, while the Srb subcomplex in yellow is important for general activities of 
RNA polymerase II. The Srb10/Cdk subcomplex in green is needed for repressing 
activity.   
 
2.5.3 From Initiation to Elongation 
Promoter clearance after initiation of transcription is closely related to the 
phosphorylation state of the carboxy-terminal repeat domain (CTD). CTD consists of 
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(YSPTSPS), and it is found at the C-terminus of the largest subunit, Rpb1p, of RNA 
polymerase II (Meinhart et al., 2005). Elongating polymerases’ CTD tails are heavily 
phosphorylated compared to those at the initiation complex (Lee and Young, 2000). 
The phosphorylation pattern on the CTD tail changes at different points in the cycle of 
transcription, resulting in the recruitment of specific RNA-processing proteins (Cho et 
al., 2001; Komarnitsky et al., 2000). Hence, researchers proposed the presence of 
CTD code hypothesizing that the various phosphorylation patterns on the CTD tail 
over the transcription cycle could couple transcription and mRNA processing 
(Buratowski, 2003). 
 
In general, the nucleosomes in front of the elongating RNA polymerase form a 
steric hindrance when the polymerase leaves the promoter for transcription. There are 
four proposals that hypothesize how elongating polymerase could overcome this 
obstacle. In the first model, nucleosomes in the path of the transcription complex are 
thought to be removed and replaced at the back of the polymerase. This is known as 
histone transfer, and it has been demonstrated for RNA polymerase III (Felsenfeld et 
al., 2000). Clearance of nucleosomes in front of the polymerase can also be displaced 
from the template resulting in histone depletion on the active gene (Lorch et al., 1987). 
In the partial stripping model, the group proposed that nucleosomes could be stripped 
from the template as the transcription complex approaches and be reassociated with 
the same DNA after the polymerase transcribed through it (Schwabish and Struhl, 
2004). Lastly in the fourth model, histone proteins were thought to unfold in response 
to an approaching polymerase. Nucleosomal “half-sites” were detected in RNA 
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polymerase II transcription supporting the histone unfolding theory (Sathyanarayana 
et al., 1999). Whether nucleosomes are transferred, displaced or unfolded, assessory 
proteins are required for proper transcription. These include Spt4, Spt5, Spt6 
(Suppressor of Ty), FACT (facilitates chromatin transcription), Elongator and the 
Swi/Snf complex (Svejstrup, 2002). 
       
2.6 Reverse Recruitment Model 
The reverse recruitment model is a newly proposed hypothesis that describes 
the movement of an activated gene to a gene expression machine (GEM) that is 
tethered to the nuclear membrane (Maniatis and Reed, 2002). This phenomenon was 
first observed in mouse L cells (Hutchison and Weintraub, 1985), and later observed 
in yeast cells. This model is in striking contrast to the recruitment model, whereby the 
activator recruits the transcription machinery, which is freely diffusing in the nucleus, 
for transcription to occur. In the reverse recruitment model, it is the genes that are 
freely diffusing and upon activation, they become attached to GEMs that are 
associated with nuclear pores (Figure 2.6). Once transcription is completed, the 
mRNA is transported out of the nucleus through the associated nuclear pore for 
translation in the Endoplasmic Reticulum (ER) (Santangelo, 2006). 
 
This idea was conceived to explain transcriptional activation that conforms 
poorly to the current recruitment model: The Rap1p/Gcr1p transcription activation. 
Rap1p (Repressor Activating Protein) has opposing roles in which it is both an 
                                                                                      Chapter 2: Survey of Literature 
 
                                                                                                                                   39
  
 
activator and a repressor. Its activating property seems to correlate with its native 
location in cells. Moreover, its activation strength was not reproducible if it was 
expressed as a fusion such as in Rap1p-LexAp (Santangelo, 2006). Evidence in 
support of the reverse recruitment model in Rap1p activation: Transcriptional 
activation requires a Nup84p nuclear pore complex (NPC), which is tethered to the 
nuclear membrane, and Rap1p together with its coactivator was also found to localize 
to the nuclear membrane (Menon et al., 2005). 
 
More recent work has also shown that some actively transcribed genes are 
closely associated with NPC at the nuclear membrane in support of the reverse 
recruitment model (Cabal et al., 2006; Schmid et al., 2006; Taddei et al., 2006). These 
genes were found to be attached to the NPC proteins via proteins in the SAGA 
complex. For instances, the actively transcribed GAL loci were found to be physically 
attached to NPC protein Mip1p by SAGA (Luthra et al., 2007). Besides the GAL loci, 
INO1 in yeast was also found to be recruited to the nuclear membrane during 
activation (Brickner and Walter, 2004). As more and more evidences now pointing 
towards gene activation via the reverse recruitment model, it has become a viable 
alternative to the recruitment model, and it appears to explain the fundamental 
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Figure 2.6 The Reverse Recruitment Model. Upon induction, an activator brings its 
target gene to the GEM, which is attached to the nuclear membrane near the nuclear 
pore. mRNA is transported to the ER for translation once transcription is completed. 
 
2.7 Protein-Protein Interaction 
Proteins are the building blocks of the cells. Most of the cell’s mass is made up 
of proteins. Their unique polypeptide sequences determine their conformation and 
function. Proteins are folded into unique conformations that enable them to function 
as enzymes, signal transducers or as structural molecules.  
 
The interactions between various proteins in the cell are exceptionally important 
especially for the process of cell signaling. Proteins can be bound to each other over a 
long period of time as they are in protein complexes or they can be interacting for 
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only a short period of time as in cell signaling. To make interactions with one another, 
the proteins make specific bonds using the functional groups of the protruding side 
chains of the amino acids. Different functional groups interact via different bonds. 
Generally, interactions are made through forming weak bonds such as hydrogen 
bonds, ionic bonds and van der waals attractions. However, strong interactions 
between proteins can be achieved by having many of these non-covalent bonds in 
parallel. This also helps to stabilize protein interactions.           
 
Eukaryotic cells are characterized by the presence of membrane-bound 
organelles. The location of a particular protein within a cell compartment suggests its 
function. A protein can be found in the cytoplasm, and it can be localized to the 
nucleus due to the regulation of certain growth factors. This indicates that the protein 
can be involved in the regulation of genes responding to these growth factors. Proteins 
generally work by interacting with each other and exerting effects as a complex. Thus, 
by studying the interacting partners of various proteins, one could predict the function 
of these proteins. This knowledge can be applied to help researchers to gain new 
insights into the cause of various human diseases.  
 
2.7.1 Methods to Study Protein-Protein Interactions 
Over the years, many methods have emerged to aid in the studies of protein 
interactions. As there are no perfect techniques, each of the different methods has 
their own strength and weakness especially in terms of sensitivity. A few of these 
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techniques are described below. 
 
2.7.1.1 Co-immunoprecipitation 
This method is standard for studying protein-protein interaction. The cell is 
lysed and the cell extract is used for analysis. The protein of interest is being pulled 
down from the extract using an endogenous antibody or if the protein of interest is 
tagged, an antibody against the tag is used. Then an affinity reagent such as those that 
can bind to the antibody linking to solid matrix is used to pull the complex out of the 
solution onto the bottom of the tube by centrifugation or filtration. The binding 
partner of the protein of interest should precipitate together with the complex, and it 
can be shown by Western Blot analysis using an antibody against this partner protein 
or against another tag used for the partner. The technique is usually used to detect 
protein partners binding in complexes in vitro. The interaction detected might be 
direct or indirect.     
 
2.7.1.2 Yeast two-hybrid 
The traditional yeast two-hybrid system is a genetic method to study protein-
protein interaction based on the transcription readout of a reporter gene in vivo (Fields 
and Song, 1989). This system makes use of the ability to split Gal4p into its DNA-
binding domain (DB) and activating domain (AD). The two halves of Gal4p are fused 
to two proteins. If the two proteins interact, Gal4p is reconstituted. The reconstituted 
Gal4p, in turn, activates the transcription of the reporter gene, and this will be shown 
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as ability of cells to grow on drop-out plates or a colour change depending on the 
reporter gene used for the assay. This method is used for screening for interacting 
partners of a protein of interest: The protein of interest or better known as “bait” is 
fused to the DB of Gal4p, while a cDNA library consisting of a variety of plasmids 
coding for different proteins is fused to the AD of Gal4p (“prey”).  
 
The classic yeast two-hybrid can be applied to detect interaction between 
two known proteins or to probe for interactions with unknown proteins expressed 
from a cDNA library. As all systems, yeast two-hybrid has a number of disadvantages. 
The most significant drawback is the restriction on the choices of the bait protein. 
Firstly, the bait protein should not be a strong activator to avoid auto-activation of the 
reporter gene by the bait construct. As the system depends on a transcriptional readout, 
the use of a repressor as bait is not suitable as well. In addition, the bait protein must 
be able to enter the nucleus. This put limitations on the type of protein partners one 
can distinguish out from the screen. This is because library proteins that are 
membrane or cytoplasmic proteins would not be detected as these proteins do not 
enter nucleus. As the false positive data resulting from this system is rather high, data 
obtained from yeast two-hybrid screens should be verified using some other protein-
protein interaction assays such as the co-immunoprecipitation. The use of two or more 
reporter genes in the assay can also help to eliminate false-positives. At the beginning, 
only one reporter, lacZ was used. Then HIS3 or LEU2 were used in conjunction with 
lacZ as reporter genes to provide a more stringent set-up.  
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Many varieties of yeast two-hybrid have surfaced over the years in order to 
counteract the disadvantages of the conventional yeast two-hybrid system or to serve 
other analysis purposes. A related technique known as reverse two-hybrid system is 
used to identify mutations that could disrupt specific protein-protein interaction 
(Causier and Davies, 2002). The choice of reporter gene is one whose expression is 
lethal to living cells should the bait and prey protein interacts. An example of such 
set-up is using URA3 as the reporter gene while plating cells on 5-fluoroorotic acid 
(FOA). The URA3 gene encodes ornithine decarboxylase, which also converts non-
toxic FOA into toxic 5-fluorouracil. Hence, the protein-protein interaction would 
trigger the expression of URA3, killing cells on FOA plates. Surviving cells are those 
which have the protein interaction disrupted (Vidal et al., 1996a; Vidal et al., 1996b).         
           
2.7.1.3 Split-Ubiquitin 
The Split-Ubiquitin system was first proposed in 1994 (Johnsson and 
Varshavsky, 1994). This assay is useful in detecting interactions between proteins 
localized at different compartments. The key molecule used in this system is a small 
protein that is highly conserved in both human and yeast. Ubiquitin is ubiquitous in 
eukaryotic cells (Doolittle, 1995). It is a small protein of about 8 kDa made up by 75 
amino acids. Its main function in cells is to mark proteins for degradation. Cells are 
quick to remove misfolded proteins or those that are no longer needed. These proteins 
are targeted for proteolysis. The proteolytic process begins with the activation of the 
ubiquitin molecule, which occurs in the presence of ATP. Activation of ubiquitin 
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requires an ATP-dependent ubiquitin-activating enzyme (E1), which transferred 
activated ubiquitin to a ubiquitin-conjugating enzyme (E2). Together with Ubiquitin 
Ligase (E3), the E2-E3 complex transfers ubiquitin to the targeted protein for 
degradation, whereby E3 functions in substrate recognition. Many classes of E3 exist, 
and these different types of classes can recognize different degradation signal on 
targeted proteins. When a targeted protein is poly-ubiquitinated, it is rapidly degraded 
by the 26S proteasome. Ubiquitin molecules are removed by deubiquitinating 
enzymes and recycled. Protein including transcription factors can also be mono-
ubiquitinated at specific lysine residues. This is a form of a post-translational protein 
modification, which can facilitate transcriptional activation or repression.    
 
The Split-Ubiquitin system is useful for analyzing protein-protein interaction. 
This method overcomes some of the limitations of the yeast two-hybrid system. One 
of the advantages of the split-ubiquitin system is that it does not depend on a 
transcriptional readout like that of yeast two-hybrid system. Hence, it is possible to 
analyze transcription factors using this system. In addition, because of the presence of 
ubiquitin-specific protease (UBPs) in the cytosol, the split-ubiquitin system is not 
restricted to nuclear proteins, but it can also be applied to probing protein interactions 
between membrane or cytosolic proteins. This system had previously been used 
successfully to detect interactions between nuclear proteins (Laser et al., 2000), 
between integral membrane proteins (Stagljar et al., 1998; Wachek et al., 2006), and 
transcription factors (Wellhausen and Lehming, 1999). The method is based on the 
ability to split ubiquitin into two halves, namely the Nub and the Cub (N-terminal and 
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C-terminal half of ubiquitin, respectively), which can be reconstituted into a native-
like ubiquitin moiety if two proteins fused to these two halves interact inside the cell. 
Once the ubiquitin molecule is reconstituted, it is recognized by the Ubps and the 
reporter protein, RUra3p, is cleaved off the Cub fusion. This brings about the N-end 
rule degradation of the reporter gene, ornithine decarboxylase, whose first amino acid 
had been changed to arginine (RUra3p). The N-end rule states that the half-life of a 
protein in the cell depends on its N-terminal amino acid and an internal lysine residue 
(Chau et al., 1989; Lehming, 2002; Varshavsky, 1997). Certain amino acids are 
thought to be destabiling residues such as basic residues or bulky hydrophobic 
residues. Examples of such amino acids include arginine, lysine, and phenylalanine. 
The protein interaction between the two proteins fused to Nub and Cub, respectively, 
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Figure 2.7 The Split-Ubiquitin assay. The ability to split the ubiquitin molecule into 
two halves with the N-terminus of ubiquitin attached to Protein X and the C-terminus 













Figure 2.8 Interaction between Protein X and Protein Y.  Interaction of the two 
proteins brings about the reconstitution of a native-like ubiquitin. The UBPs will 
cleave off RUra3, leading to the degradation of RUra3p via the N-end rule. 
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3 METHODS AND MATERIALS 
3.1 Materials 
3.1.1 Yeast Strains  
Table 3.1 Genotype of the parental yeast strains used in this study.  
Parental Yeast Strain Genotype 
NLY2 MATα ∆gal4 ∆gal80 ∆ade2 ura3-52 leu2-1 
his3∆200 lys2::hisG (Saha et al., 1993) 
NLY2::HIS3∆TBP1 + 
pYCplac33-TBP1 
MATα ∆gal4 ∆gal80 ∆ade2 ura3-52 leu2-1 
his3∆200 trp1::hisG lys2::hisG TBP1::his3 
[pYCplac33-TBP1] (N. Lehming) 
JD52 MATα ura3-52 leu2-3 his3∆200 lys2-801 trp1∆63 
(Dohmen et al., 1995) 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
(EUROSCARF) 
BY4741∆W MATa his3∆1 leu2∆0 met15∆0 ura3∆0 trp1::hisG 
(N. Lehming) 
BY4741∆W∆UBP3 MATa his3∆1 leu2∆0  met15∆0 ura3∆0 
trp1::hisG ubp3::KanMX4; HIS3 gene repaired 
(N.Lehming) 
BY4742∆GCN4 MATα his3∆1 ura3∆0 leu2∆0 lys2∆0 
gcn4::kanMX4 (EUROSCARF) 
SUB288∆W∆L + pPactT316-Ub MATα lys2-801 leu2-3 112 ura3-52 his3-∆200 
trp1-1 ubi1::TRP1::hisG ubi2-∆2::ura3 
ubi3-∆ub2 ubi4-∆2::LEU2::hisG (N.Lehming) 
The endogenous TBP1 gene in NLY2 had been replaced with the HIS3 gene 
by homologous recombination in the presence of pYCplac33 (Gietz and Sugino, 1988) 
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containing the wild-type TBP1 gene. Mutant TBP1 alleles were introduced into 
competent yeast cells with the respective expression plasmids followed by the 
removal of the wild-type TBP1 allele by plating the cells on 5-fluoro-orotic acid 
(FOA) plates. 
 
The parental yeast strains BY4741∆W, BY4742∆GCN4, and 
BY4741∆W∆UBP3 were derived from EUROSCARF (the European Saccharomyces 
cerevisiae Archive for Functional Analysis; http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/col_index.html). The TRP1 gene was deleted with 
the help of NKY1009 (Alani et al., 1987).  
 
3.1.2 Plasmids 
Table 3.2 Various plasmids used in this study 
Plasmids Description Remarks 
pYCplac22 (TRP1 
marker) (Gietz and 
Sugino, 1988) 
ARS-CEN (Single-copy) plasmid. TBP1 was 
under the control of its endogenous promoter. 
• pYCplac22-TBP1 
• pYCplac22-TBP1(E186D) 
• pYCplac22-TBP1(I143N)  
pASZ11 (ADE2 
marker)  
ARS-CEN (Single-copy) plasmid. TBP1 and 
GAL4 were under the control of their own 





pY (TRP1 marker) 
 
2µm (Multi-copy) plasmid. GAL4 was under the 
control of the ADH1 promoter and terminator. 
• pYGAL4 
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pYCplac33 (URA3 
marker) (Gietz and 
Sugino, 1988) 
ARS-CEN (Single-copy) plasmid. TBP1 was 







Wittke et al., 1999) 
ARS-CEN (Single-copy) plasmid. Cub fusions 
under the control of the CUP1 promoter and 
URA3 terminator. 
• TBP1-Cub-RUra314 






et al., 1989)  
 
ARS-CEN (Single-copy) plasmid. For the cloning 
of SUA7, SRB4, RPB1, RPB4, and RPB8 gene as 
fusions to Nub. Nub-fusions were under the control 












2µm (Multi-copy) plasmid. GST-Tbp1p was 









2µm (Multi-copy) plasmid. UBP3 was expressed 







ARS-CEN (Single-copy) plasmid. Ubiquitin was 








ARS-CEN (Single-copy) plasmid. Ubiquitin was 
expressed under the control of the ACT1 promoter 
and terminator. 
• pPactT316-Ub 
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3.1.3 Bacterial strains 
Table 3.3 Genotype of the bacterial strains used in this study.  
Bacterial strain Genotype 
DH10B  
 
F-mcrA ∆(mrr-hsdRMS-mcrBC) Φ80dlacZ∆M15 ∆lacX74 deoR recA1 
endA1 araD139∆(ara,leu)7697 galU galK λ- rpsL nupG 
DH5α 
 
deoR, endA1, gyrA96, hsdR17(rk-mk+), recA1, relA1, supE44, thi-1, 
∆(lacZYA-argFV169), f80lacZ∆M15, F- 
DH10B: Escherichia coli cells that were used for the electroporation of plasmids.  
DH5α: Escherichia coli cells that were used for heat transformation of plasmids. 
Both DH10B and DH5α E.coli cells were made competent by the lab officer-in-
charge. 
 
3.1.4 Primers for PCR and sequencing  
Table 3.4 Primers used in this study. 
Gene Primer Name PCR primer sequences 
N-terminus of Ubiquitin and 
ADH1 terminator of pPACNX 
5' Nub 
3' 1995 
5' gccaagcttatgcagattttcgtcaagac 3' 
5' ctaccaacgatttgaccctt 3' 
GAL1 ORF GAL1 Forward 
GAL1 Reverse   
5' acttgcaccggaaaggtttg 3' 
5' ttggtacatcaccctcacagaaga 3' 
GAL1 Promoter 5' GAL1 Forward 
3' GAL1 1+60 
5' taacctggccccacaaacct 3' 
5' cggccaatggtcttggtaat 3' 
ACT1 ORF 5' ACT1 Forward 
3' ACT1 Reverse 
5' aaaccgctgctcaatcttct 3' 
5' aataccggcagattccaaac 3' 
Terminator of SUA7 + HpaI site 5' TSua7-HpaI 
3' TSua7-PacI 
5' gccgccgttaacagtaaattataggaaca 3' 
5' gccgcttaattaatatgatgaatcaagtag 3' 
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3.1.5 Culture plates and broth 
Table 3.5 Culturing plates and broth required for experiments. 
Types of Plates* Description  
WL 2% Glucose agar plates with amino acid premix lacking 
tryptophan (W) and leucine (L). 
UWL 2% Glucose agar plates with amino acid premix lacking uracil 
(U), tryptophan (W) and leucine (L). 
10/100 UWL 2% Glucose agar plates with amino acid premix lacking uracil 
(U), tryptophan (W) and leucine (L) with 10/100µM copper 
sulfate (CuSO4). 
WU 2% Glucose agar plates with amino acid premix lacking 
tryptophan (W) and uracil (U). 
WL FOA 2% Glucose agar plates with amino acid premix lacking 
tryptophan (W) and leucine (L) with 0.85g/L 5-Fluoro-orotic 
acid. 
AWL Glu 2% Glucose agar plates with amino acid premix lacking adenine 
(A), tryptophan (W) and leucine (L). 
1.0 AWL Gal 2% Galactose agar plates with amino acid premix lacking 
adenine (A), tryptophan (W) and leucine (L) with 1µg/L 
antimycin A (MERCK). 
AWL Glu Broth 2% Glucose broth with amino acid premix lacking adenine (A), 
tryptophan (W) and leucine (L).  
AWL Gal Broth 2% Galactose broth with amino acid premix lacking adenine 
(A), tryptophan (W) and leucine (L).  
YPDA broth and plate Yeast peptone dextran adenine broth and plate. 
LB + Chl or Amp plates /broth Luria Bertani with chloramphenicol (10mg/ml) or ampicillin 
(50mg/ml) 
His + 50 mM AT 2% Glucose agar plates with amino acid premix lacking histidine 
with 50mM 3-aminotriazole (Sigma; Cat. No. A8056-100G) 
*Constituents of each culturing plates and broth are found in Appendix 7.1 
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3.2 Methods 
3.2.1 Phenotypes displayed by yeast cells carrying the TBP1(E186D) 
mutation 
NLY2::HIS3∆TBP1 + pYCplac33-TBP1 cells were made competent using the 
lithium acetate method (Section 3.2.12). Either pYCplac22-TBP1, pYCplac22-
TBP1(E186D) or pYCplac22-TBP1(I143N) was transformed into competent 
NLY2::HIS3∆TBP1 + pYCplac33-TBP1 (Section 3.2.13). The transformants were 
spread on plates lacking tryptophan. The transformants were incubated at 28°C for 3 
days before single colonies were picked, and re-streaked on glucose plates lacking 
tryptophan containing FOA (5-Fluoro-orotic acid; Bio Vectra; Cat. No.1556). Re-
streaked yeast candidates were incubated at 28°C for 3 days. Yeast candidates that 
were able to grow on FOA plates were made competent using the lithium acetate 
method. Competent NLY2::HIS3∆TBP1 carrying pYCplac22-TBP1 were 
transformed with empty vector or pASZ11-GAL4, whereas NLY2::HIS3∆TBP1 
carrying pYCplac22-TBP1(E186D) or pYCplac22-TBP1(I143N) were transformed 
with pASZ11-GAL4 (Section 3.2.13). Transformants were selected on plates lacking 
tryptophan and adenine for 3 days at 28°C. To test for gal- phenotype, 3-
aminotriazole-sensitivity, and temperature-sensitivity due to the TBP1(E186D) 
mutation, droplet assay (Section 3.2.15) on selective medium with antimycin A, 3-
aminotriazole (Sigma; A8056-100G), and incubation at 35°C were performed, 
respectively (Table 3.5). Negative control used for analysis of 3-aminotriazole-
sensitivity was BY4742∆GCN4 transformed with pYCplac22 and 
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pPACNX-Nub-SUA7. 
Table 3.6 Yeast cells carrying the depicted plasmids to investigate phenotypes 
caused by TBP1(E186D).  
Strains Plasmids 
pYCplac22-TBP1 + pASZ11 
pYCplac22-TBP1 + pASZ11-GAL4 
pYCplac22-TBP1(E186D) + pASZ11-GAL4 
NLY2∆TBP1::HIS3 
pYCplac22-TBP1(I43N) + pASZ11-GAL4 
BY4742∆GCN4 pYCplac22-TBP1 + pASZ11 
 
3.2.2 Screening for suppressors of TBP1(E186D) temperature- 
sensitivity 
The ARS-CEN (single-copy) vectors expressing the Nub fusions were under 
the control of the ADH1 promoter/terminator cassette (Colicelli et al., 1989). SUA7, 
SRB4, RPB1, RPB4, and RPB8 borne on pPACNX-Nub were amplified with the help 
of PCR using Promega Taq polymerase. The PCR fragments of individual genes were 
transformed into competent NLY2∆TBP1::HIS3 + pYCplac22-TBP1(E186D) via 
gapped repair (Lehming et al., 1995). To isolate suppressors of temperature-
sensitivity, the transformants were incubated at 35°C. All candidates acquired were 
tested for plasmid linkage. The candidates were grown to turbidity using 10 ml of 
glucose selective medium with agitation overnight. The cells were harvested for yeast 
breaking (Section 3.2.14), and DH10B E.coli competent cells were transformed with 
the acquired plasmids via electroporation for plasmids amplification (Section 3.2.18). 
The transformants were plated on LB plates with chloramphenicol, and the plates 
were incubated at 37°C overnight. Colonies grown on plates were inoculation into LB 
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broth with chloramphenicol at 37°C overnight with agitation. Plasmid rescue was 
done by performing DNA minipreparation (Section 3.2.19). The plasmids retrieved 
were digested with NotI/HindIII to ensure the presence of an inserted gene. 
Competent parental yeast cells were transformed with the positive candidates to check 
for plasmid linkage. DH5α E.coli were transformed with candidates that were shown 
to be plasmid linked (Section 3.2.17) for plasmid multiplication. Plasmid linked 
candidates were sequenced using 5'Nub and 3'1995 primers (Section 3.2.20).  
 
3.2.3 The suppressive effect of SUA7(E202G) on TBP1(E186D) 
phenotypes 
To investigate if SUA7(E202G) suppressed the gal- phenotype of TBP(E186D), 
pASZ11-GAL4, an ADE2-marked single-copy vector containing the entire GAL4 
gene, was transformed into NLY2∆TBP1::HIS3 + pYCplac22-TBP1(E186D) together 
with pPACNX-Nub-SUA7(E202G) or pPACNX-Nub-SUA7 (Section 3.2.13). 
Transformants were grown on plates with selective glucose medium lacking adenine, 
tryptophan and leucine at 30°C for 3 days. Droplet assay (Section 3.2.15) was 
performed on galactose plates containing 1 µg/ml antimycin A. The suppressing effect 
of SUA7(E202G) on the 3-aminotriazole-sensitivity phenotype was also tested by 
performing droplet assay on glucose plates with 50 mM 3-aminotriazole. In addition, 
we tested SUA7(E202G) for allele specificity by using another TBP1 temperature 
sensitive allele, TBP1(I143N).  The plates were observed after 3 or more days of 
incubation. 
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Table 3.7 Yeast cells with the depicted plasmids to investigate the suppression 
effect of SUA7(E202G) on the phenotypes displayed by TBP1(E186D).  
Strain  Plasmids 
pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11 
pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11-GAL4 
pYCplac22-TBP1 + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7 +pASZ11-GAL4 
pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
pYCplac22-TBP1(I43N) + pPACNX-Nub-SUA7 + pASZ11-GAL4 
NLY2∆TBP1::HIS3 
pYCplac22-TBP1(I43N) + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
BY4742∆GCN4 pYCplac22-TBP1 + pASZ11 
 
3.2.4   Analysis of protein-protein interactions between Tbp1-Cub-
RUra3p or Tbp1(E186D)-Cub-RUra3p with Nub-fusions of 
Sua7p or Sua7(E202G)p  in vivo using the Split-Ubiquitin 
assay 
Competent BY4741∆W cells expressing Tbp1-Cub-RUra3p or 
Tbp1(E186D)-Cub-RUra3p under the control of the CUP1 promoter were transformed 
with Nub and Nub-fusions of Sua7p or Sua7(E202G)p (Section 3.2.13). Transformants 
were grown on control plates lacking tryptophan and leucine for 3 days. After 3 days, 
droplet assays were carried out (Section 3.2.15). Transformants were grown on 
control plates lacking tryptophan and leucine and on plates additionally lacking uracil 
in the absence and presence of 100 µM CuSO4 at 39°C for 3 days. 
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Table 3.8 Yeast strains with depicted plasmids to investigate the ability of 
Sua7(E202G)p to restore interaction with Tbp1(E186D)p. 
Strains Plasmids 
TBP1-Cub-RURA3 + pPACNX-Nub 
TBP1-Cub-RURA3 + pPACNX-Nub-SUA7 
TBP1-Cub-RURA3 + pPACNX-Nub-SUA7(E202G) 
TBP1(E186D)-Cub-RURA3 + pPACNX-Nub 
TBP1(E186D)-Cub-RURA3 + pPACNX-Nub-SUA7 
BY4741∆W 
TBP1(E186D)-Cub-RURA3 + pPACNX-Nub-SUA7(E202G) 
 
3.2.5 Complementation of GST-Tbp1p fusion proteins  
The GST-Tbp1p fusions were cloned into pYG1µ, a multi-copy vector 
expressing GST under the control of ADH1 promoter. Competent 
NLY2∆TBP1::HIS3 + pYCplac33-TBP1 cells were transformed with pYG1µ, 
pYG1µ-TBP1 or pYG1µ-TBP1(E186D), as well as with pPACNX-Nub, pPACNX-
Nub-SUA7 or pPACNX-Nub-SUA7(E202G) (Section 3.2.13). The HA-Sua7p fusions 
were cloned into pPACNX-Nub, and expressed under the control of the ADH1 
promoter. The transformants were plated and incubated on plates lacking tryptophan 
and leucine at 30°C for 3 days. Transformants were picked for droplet assays (Section 
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Table 3.9 Yeast cells with the depicted plasmids to investigate the 
complementation of GST-fusion protein on NLY2 strain.  
Strains Plasmids 
pYG1µ + pPACNX-Nub-SUA7 
pYG1µ + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1 + pPACNX-Nub-SUA7 
pYG1µ-TBP1 + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1(E186D) + pPACNX-Nub-SUA7 
pYG1µ-TBP1(E186D) + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1(I143N) + pPACNX-Nub-SUA7 
NLY2∆TBP1::HIS3 
pYG1µ-TBP1(I143N) + pPACNX-Nub-SUA7(E202G) 
 
3.2.6   Analysis of protein-protein interactions using affinity 
precipitation 
3.2.6.1 Analysis of protein-protein interactions between GSTp, GST-Tbp1p, 
GST-Tbp1(E186D)p  or GST-Tbp1(I143N)p with Nub-Sua7p or Nub-
Sua7(E202G)p in vitro using GST pulldown  
Growing of yeast strains for GST pulldown 
The GST-Tbp1p fusions were cloned into pYG1µ, a multi-copy vector 
expressing GST under the control of ADH1 promoter. Competent JD52 cells were 
transformed with pYG1µ, pYG1µ-TBP1 or pYG1µ-TBP1(E186D), as well as with 
pPACNX-Nub, pPACNX-Nub-SUA7 or pPACNX-Nub-SUA7(E202G) (Section 3.2.13). 
The HA-Sua7p fusions were cloned into the single-copy vector pPACNX-Nub, and 
expressed under the control of the ADH1 promoter. Transformants were plated onto 
glucose plate lacking tryptophan and leucine for incubation at 30°C for 3 days.  
                                                                              Chapter 3: Methods and Materials 
 59
Table 3.10 Yeast cells with the depicted plasmids used for GST-pulldown assay. 
Strain Plasmids 
pYG1µ + pPACNX-Nub 
pYG1µ + pPACNX-Nub-SUA7 
pYG1µ + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1 + pPACNX-Nub-SUA7 
pYG1µ-TBP1 + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1(E186D) + pPACNX-Nub-SUA7 
pYG1µ-TBP1(E186D) + pPACNX-Nub-SUA7(E202G) 
pYG1µ-TBP1(I143N) + pPACNX-Nub-SUA7 
JD52 
pYG1µ-TBP1(I143N) + pPACNX-Nub-SUA7(E202G) 
 
Glutathione Sepharose beads pulldown 
GST-pulldown assays were performed with cell extracts. Yeast strains prepared 
for GST-pulldown assays were inoculated into broth lacking tryptophan and leucine. 
Culture were incubated at 28°C with agitation until growth reached OD600nm=1.0. The 
cultures were harvested by centrifuging at 3220 x g for 5 minutes. Each cell pellet was 
washed with 1 ml of sterile distilled water and centrifuged for 1 minute at 2940 x g. 
Each cell pellet was re-suspended in 1 ml of yeast lysis buffer (100 mM Tris pH 7.5, 
50 mM KCl, 1 mM EDTA, 0.1% NP40) with 2 mM of PMSF 
(Phenylmethanesulphonyl fluoride; BDN Cat. No. 442172C), and approximately 600 
µl of glass beads was added to lyse cells via mechanical homogenization. The cells 
were homogenated at high speed using a bead beater for 1 minute before cooling on 
ice for another 1 minute. The process was repeated for 3 times. The cell lysate was 
pipetted out into fresh eppendorf tubes, and centrifuged at 10140 x g for 30 minutes. 
The supernatant cell extract was transferred to a fresh eppendorf tube and stored at -
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80°C until needed. 300 µl of each sample was used for the pulldown assay using 
GST-beads (Glutathione SepharoseTM 48; Amersham Biosciences; 17-0756-01). The 
beads were washed with 1 ml yeast lysis buffer, and centrifuged at 2940 x g for 1 
minute.  This process was repeated for three times before 10 µl of washed GST-beads 
was added to each pulldown reaction. 2 mM of PMSF was also pipetted into each 
reaction. The cell lysate together with the beads were incubated at 4°C for an hour. 
After one hour, the pulldown reaction was centrifuged at 2940 x g for 1 minute. The 
supernatant was removed after centrifugation. The beads were washed with 1 ml yeast 
lysis buffer for three times before 10 µl of 2X SDS loading dye was added into each 
pulldown candidate for SDS-PAGE electrophoresis.    
 
3.2.6.2 Ubiquitination of Tbp1p (Nickel Beads pulldown)  
Competent SUB288∆W∆L + pPactT316-Ub cells were transformed with 
pYCplac22-HA-TBP1 and either pPactT317-Ub or pPactT317-H10-Ub (Section 
3.2.13). The transformants were plated onto plates lacking tryptophan and lysine and 
incubated for 3 days at 30°C. Single colonies were re-streaked onto plates lacking 
tryptophan and lysine with FOA to remove pPactT316-Ub. After 3 days of incubation, 
transformants were inoculated into glucose selective media and incubated at 30°C 
overnight on a shaker. Cells were harvested for lysis at OD600nm=1.0. Yeast lysis was 
done as above using a bead beater except that each cell pellet was re-suspended with 1 
ml yeast breaking buffer (2% v/v Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-
HCl pH 8, 1mM EDTA) of a higher SDS concentration instead of that used in the 
yeast lysis buffer. The total amount of nickel beads needed was pipetted out into an 
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eppendorf tube and was pre-washed with 1 ml yeast breaking buffer for 3 times. In 
between washes, the beads were put on rotor for 5 minutes to ensure proper mixing 
and washing of beads. Washed beads were centrifuged at 375 x g for 5 minutes. At 
the end of the third wash, the beads were re-suspended with approximately the same 
amount of yeast breaking buffer. For each pulldown reaction, 10 µl of beads were 
pipetted into 300 µl of yeast extract. 2 mM of PMSF was added to each reaction, and 
the reaction volume was topped up to 500 µl using yeast breaking buffer. Proteins 
were incubated at 4°C for one hour on a rotor. For the pulldown, the beads were 
centrifuged down at 375 x g and the supernatant was discarded. The beads were 
washed with 1 ml yeast breaking buffer for 3 times. In between washes, the beads 
were put on a rotor for 5 minutes to ensure proper washing. After the final wash, the 
beads were re-suspended with 25 µl elution buffer (500 mM Imidazole yeast breaking 
buffer). Elution was done at 37°C for 10 minutes. Samples were centrifuged at 375 x 
g for 5 minutes, and the eluant was pipetted to a fresh eppendorf tube. Elution was 
repeated with another 25 µl elution buffer, followed by incubation at the same 
temperature for an hour. A total of 50 µl eluted sample was collected for each 
pulldown reaction, and 20 µl was used for Western blot analysis. 12 µl of pre-
pulldown sample was used as input.    
Table 3.11Yeast cells with the depicted plasmids used for detection of ubiquitin 
Tbp1p.  
Strain Plasmids 
pYCplac22-HA-TBP1 + pPactT317-Ub SUB288∆W∆L + pPactT316-Ub 
pYCplac22-HA-TBP1 + pPactT317-H10-Ub 
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3.2.7 SDS-PAGE and Western blot Analysis 
A 10% polyacrylamide gel was used for detection of endogenous Tbp1p and 
HA-tagged Tbp1p while a 12% polyacrylamide gel was used for GST-Tbp1p. The 
Biorad SDS-PAGE system was used for the preparation of SDS-PAGE gels needed 
for Western blot analysis. The separating gel was casted first, and a thin layer of 
isoproponol was added before the separating gel solidified so as to get rid of the 
bubbles that might form during casting. Isoproponol was removed before the stacking 
gel was casted. The comb was put in between the two glass plates to set loading wells 
in the stacking gel. Formulations of the SDS-PAGE gel are listed in Table 7.1 and 
Table 7.2 in Appendix 7.3.  
 
The SDS-PAGE gel was mounted onto the gel tank. For running experiment 
using cell pellets, the cell pellet (yeast cells inoculated into 2 ml of selective medium, 
and harvested at OD600nm=1.0) was re-suspended in 10 µl of distilled water, and 10 µl 
of 2X loading dye. For the pulldown assay, 10 µl of 6X loading dye was added. After 
adding loading dye, the prepared samples were heated at 95°C for 5 minutes, and 
were loaded onto the SDS-PAGE well. 5 µl of marker standard (Kaleidoscope 
Prestained Standard from Bio-Rad Laboratories) was loaded onto the first well. 
Electrophoresis was carried out at 100 V for 30 minutes at room temperature and then 
increased to 180 V for another 40 minutes before the SDS-PAGE gel was removed 
from the electrophoresis tank for protein transfer onto membrane.  
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To transfer proteins onto membranes, Semi-Dry Electrophoretic Transfer Cell 
(Bio-Rad Laboratories) system was used. Transfer buffer was prepared using 60 ml 
distilled water, 20 ml of 5X transfer buffer, and 20 ml Methanol. To begin, four 
pieces of filter papers were pre-soaked with the freshly-prepared transfer buffer. They 
were put onto the platinum anode before putting the pre-wet nitrocellulose membrane 
(Trans-Blot Transfer Membrane Pure Nitrocellulose Membrane 0.2 µM; Cat. No.162-
0112) on top. The SDS-PAGE gel was placed on top of the membrane followed by 
another four pieces of filter paper pre-soaked with transfer buffer. Transfer was 
carried out for 60 minutes at 0.18A. After protein transfer was finished, blocking was 
done by soaking the membrane with 10mM Tris HCl (pH 7.4) containing 5% skim 
milk for 1 hour on an orbital shaker at 4°C. After blocking, the primary antibody was 
added, and incubated overnight on an orbital shaker at 4°C. For mouse anti-GST, 
mouse anti-haemagglutinin, and rabbit anti-Tbp1p antibody, a 1:10,000 dilution in 
5 % skim milk TBST (20 mM Tris, 150 mM NaCl, 0.1% Tween-20) was used.   
 
The membrane was washed three times with TBST for 15 minutes each time 
before incubating with a secondary antibody for at least 1 hour. The secondary 
antibody for mouse anti-GST and mouse anti-HA was rabbit anti-mouse horseradish 
peroxidase (HRP), and a 1:10,000 dilution in 5% skim milk TBST was used. For 
rabbit anti-Tbp1p, the secondary antibody was goat anti-rabbit-HRP. A 1:2,941 
dilution in 5% skim milk TBST was used. The membrane was washed three times 
with TBST before substrate (2 ml of solution A and 50 µl of solution B; ECL Plus 
western blotting detection RPN 2132) was added for 1 minute onto the membrane. 
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The membrane was wrapped by clingwrap and transferred to a cassette. Exposure of 
autoradiography film was done a dark room with film safe red light. The film was put 
on top of the membrane for different times, and the film was developed using the 
developing facilities in the Clinical Research Centre, NUS.  
 
3.2.7.1 Coomassie blue staining 
To determine if the loading of different protein samples were similar, we did 
coomassie staining on SDS-PAGE gels after loading 15 µl of the protein extract of 
each sample. After electrophoresis, the gel was placed in a container with coomassie 
blue dye (0.1% coomassie brilliant blue R-250, 50% absolute ethanol, 10% acetic 
acid), and left on a shaker for an hour. Then the gel was destained overnight with 
destaining solution on an orbital shaker (45% absolute ethanol, 10% acetic acid, and 
45% distilled water). Coomassie blue staining was also done on the membrane after 
exposure. The membrane was washed with distilled water, stripping buffer (0.2 M 
NaOH), and finally with distilled water for 5 minutes each. Then coomassie stain was 
added to stain the membrane for 2 minutes. The membrane was rinsed with distilled 
water before destaining with destaining buffer overnight.   
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3.2.8 Analysis of GAL1 transcription level by Real-Time PCR 
3.2.8.1 The analysis of GAL1 mRNA transcription level in cells expressing 
Sua7p or Sua7(E202G)p  in TBP1(E186D) background upon galactose 
induction using Real-Time PCR 
Preparation of yeast cells for Real-time PCR Analysis  
Competent NLY2∆TBP1::HIS3 cells expressing Tbp1p or Tbp1(E186D)p 
were transformed with ARS-CEN plasmids expressing Nub-fusions of Sua7p and 
Sua7(E202G)p together with pASZ11 or pASZ11-GAL4 (Section 3.2.13). 
Transformants were inoculated into 20 ml of glucose selective medium lacking 
adenine, tryptophan and leucine. The cells were incubated at 28°C with agitation until 
they reached OD600nm=1.0. The cells were harvested by centrifuging at 3220 x g for 5 
minutes, and cell pellets were washed with 50 ml sterile water before centrifugation 
for a second time at the same speed. The cell pellets were re-suspended into 20 ml of 
2% galactose selective medium lacking adenine, tryptophan and leucine for 
incubation of another 1 hour at the same temperature, and with agitation as mentioned 
above. After the 1 hour of induction, cells were centrifuged at 3220 x g for 5 minutes. 
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Table 3.12 Yeast cells with the depicted plasmids for Real-Time PCR analysis. 
Strain Plasmids 
pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11 
pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11-GAL4 
pYCplac22-TBP1 + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7 + pASZ11 
pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7 + pASZ11-GAL4 
NLY1∆TBP1::HIS3 
pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
 
3.2.8.2 The analysis of GAL1 mRNA transcription level in UBP3-deleted cells 
upon galactose induction using Real-Time PCR 
Preparation of yeast cells for Real-Time PCR analysis 
BY4741∆W∆UBP3 was made competent via the lithium acetate method 
(Section 3.2.12). Competent cells were transformed with either pYCplac22 or 
pYCplac22-UBP3 (Section 3.2.13). The transformants were plated onto glucose plates 
lacking tryptophan. The plates were incubated at 30°C for 3 days. After incubation, 
the cells were inoculated into 50 ml glucose selective medium lacking tryptophan for 
incubation at 30°C overnight, with agitation until OD600nm=1.0. Yeast cells were 
transferred to a 50 ml falcon tube and harvested by centrifugation at 3220 x g for 5 
minutes. The pellets were re-suspended in 1 ml sterile distilled water and transferred 
to eppendorf tubes before centrifuging at 2940 x g for 1 minute. The water was 
discarded, and pellets were kept at -80°C until needed. These samples were labeled as 
non-induced.  For galactose-induction, after growth in glucose medium reached 
OD600nm = 1.0, cells were harvested by centrifuging at 3220 x g for 5 minutes. The 
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supernatants were removed and cell pellets were re-suspended and washed with 50 ml 
sterile distilled water. The centrifugation step was repeated, and water was removed. 
Galactose-induction was carried out by re-suspending cell pellets in 50 ml galactose 
selective medium. Yeast cells were transferred to 200 ml flasks for incubation at 28°C 
for 2 hours with agitation. Yeast cells were harvested and washed as described above 
before keeping the cell pellets at -80°C until ready to proceed. 
Total RNA isolation 
Total RNA isolation was done using RNeasy Mini Kit (QIAGEN; Cat. 
No.74104). Yeast cells harvested from were homogenized using mechanical 
disruption. Each cell pellet was re-suspended in 1 ml of the RLT buffer provided with 
the kit. 10 µl of beta-mercaptonol was added per 1 ml of RLT buffer before lysis. 
Approximately 600 µl of acid-washed glass beads (425-600 µm) were added to each 
cell pellet. The pellets were homogenated at top speed using a bead beater for 1 
minute and cooled on ice for another minute. The procedure was repeated three times 
before the lysates were pipetted into fresh eppendorf tubes. Total RNA was isolated 
from these samples using the RNeasy spin column as described in the RNeasy Mini 
Kit Handbook. RNA was eluted from the RNeasy spin column with 50 µl RNase-free 
water. RNA yield was quantitated at OD260nm using a spectrophotometer. The integrity 
and size distribution of total RNA purified using RNeasy Mini kit was checked by 
denaturing gel electrophoresis, and the 28S and 18S rRNA of each sample should 
appear as sharp bands. This indicated that the integrity of rRNA and mRNA in 
samples was not degraded during the extraction procedure.     
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Preparation and running of formaldehyde gels for rRNA analysis   
1.2 g of agarose (UltraPure agarose; GibcoBRL Cat. No. 15510-027) was 
measured into a flask containing 10 ml of 10x FA buffer (Table 7.3), and 90 ml of 
RNase-free water. The agarose suspension was heated in a microwave till the agarose 
powder had completely dissolved in the buffer. The melted gel mixture was allowed 
to stand to cool till around 65°C before adding 1.8 ml of formaldehyde, and 3 µl of 
ethidium bromide. The gel mixture was poured into the gel caster and left till 
solidified. 2 µl of each sample was mixed with 2 µl of RNA loading buffer. The 
samples were heated at 65°C for 5 minutes and chilled on ice for 5 minutes before 
loading. 5 µl of RNA ladder (RiboRuler RNA Ladder High Range; Fermentas) was 
loaded onto the first well before electrophoresis was carried out at 80 V for 40 
minutes using 1 X FA gel running buffer (Table 7.4). Preparation and electrophoresis 
of the gel was carried out in the fumehood due to the usage of formaldehyde. 
DNase treatment 
 
Following total RNA isolation, DNase treatment was performed using the 
DNase treatment kit (DNA-free™ from Ambion; Cat. No.1906). Each sample was 
diluted to 100 µg/ml in a total of 30 µl of RNase-free water. All the required reagents 
as listed below were pipetted into the diluted sample. The digest was carried out for 1 
hour at 37°C. After 1 hour of incubation, an additional 1 µl of rDNase was added, and 
the samples were further incubated for another hour at 37°C. The digested samples 
were tested for presence of remaining DNA by performing PCR reaction as listed 
below. The PCR reaction was separated on a 2% agarose gel at 100 V for 40 minutes. 
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Table 3.13 Reaction mix for DNA-free protocol.  
Reagent Quantity (µl) 
RNA sample (100 µg/ml)  30  
rDNase 1  
10 X rDNase working buffer 3.3  
 
Table 3.14 Reaction mix for PCR. 
Reagent     Quantity (µl) 
10 X PCR buffer 5 
10 mM dNTPs 0.5 
10 µM GAL1 Forward Primer 0.5 
10 µM GAL1 Reverse Primer 0.5 
25 mM MgCl2 4 
Taq Polymerase 0.5 
RNase-free water 9 
CDNA 5 
Total Volume 25µl/ tube 
 
Table 3.15 PCR condition used to detect presence of remaining DNA after DNA-
free protocol. 
Step Temperature   Time 
1 95°C 5min 
2 95°C 30sec 
3 50°C 30sec 
4 72°C 1min (Back to Step 2; repeat 39 times 
5 72°C 10min 
The reaction was carried out for 40 cycles and hold at 4°C upon completion. 
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Reverse-Transcriptase PCR (RT-PCR) 
Pure RNA samples after treatment with DNA-free protocol was subjected to 
RT-PCR in order to generate cDNA. RT-PCR was done using TaqMan® Reverse 
Transcription from Applied Biosystems; Cat No.N808-0234. 10 µl of each sample 
was used, and the different reagents required for RT-PCR are shown below. A master 
mix was prepared, and the reagents were pipetted into PCR tubes followed by the 
10 µl of DNase treated RNA. Each reaction was mixed well and pulsed down using a 
centrifuge. The RT-PCR was performed as listed below.  To determine if cDNA had 
been generated, PCR reaction was performed on each sample with conditions similar 
to what was mentioned above (Table 3.14 and Table 3.15).  
 
Table 3.16 Reaction mix for RT-PCR. 
Reagent Quantity (µl) 
10X Reverse Transcription Buffer 3  
25 mM MgCl2 6.6l 
2.5 mM dNTPs 6  
50 µM Random Hexamer 1.5 
20 U/L RNase inhibitor 0.6 
50 U/L Reverse Transcriptase 0.75  
RNase-free water 1.55  
100 ng/µl RNA 10  
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Table 3.17 RT-PCR condition. 




RT-PCR reaction was hold at 25°C after completion 
Real-Time PCR 
Real-time PCR was performed with SYBR-Green (SYBR Green PCR Master 
Mix from Applied Biosystems; Cat. No.4309155). The primers used were GAL1 ORF 
primers (Forward 5' acttgcaccggaaaggtttg 3'; Reverse 5' ttggtacatcaccctcacagaaga 3') 
and ACT1 ORF primers (Forward 5' aaaccgctgctcaatcttct 3' Reverse 5' 
aataccggcagattccaaac 3') as internal control. A master mix of each pair of primers was 
used. 5 µl of cDNA were added to 20 µl of real-time PCR mix. Real-time PCR was 
performed with optical tubes and caps (Optical tubes/ Caps from Applied Biosystem 
P/N 4316567). The readings were normalized against NLY2∆TBP1::HIS3 cells co-
expressing Sua7p and Tbp1p or Tbp1(E186D)p without Gal4p. Real-time PCR was 
performed using Applied Biosystems 7300 Real Time PCR System provided by the 
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Table 3.18 Reaction mix for Real-Time PCR. 
Reagent Quantity (µl) 
2 X SYBR Green PCR master mix  12.5  
10 µM Forward Primer 0.3 
10 µM Reverse Primer 0.3 
Nuclease Free Water 6.9 
cDNA 5 
Total Volume 25µl/ tube 
       
3.2.9 Analysis of gene expression in TBP1(E186D) background in 
the presence of SUA7(E202G) using DNA Microarray 
Analysis 
3.2.9.1 Preparation of the SUA7(E202G) knock-in strain 
PCR was carried out to amplify the SUA7 terminator from the yeast genomic 
DNA library 366 using the primer 5' TSua7-HpaI and 3' Sua7 PacI. 10 µl of the PCR 
product was separated on an agarose gel to see if the PCR reaction was successful. 
Upon confirmation, the PCR product was purified using purification kit (High Pure™ 
PCR Product Purification Kit from Boehringer Mannheim; Cat. No.1732676). A 
double digest on PCR fragment using restriction enzymes KSPAI and PacI was done. 
pPACNX-Nub-SUA7 and pPACNX-Nub-SUA7(E202G) were also digested with 
similar enzymes for 2 hours. Purification of digested PCR fragment and pPACNX 
plasmids was performed before ligation overnight (Section 3.2.16). Competent E.coli 
DH5α cells were transformed with ligated plamids (Section 3.2.17). Restriction 
digestion after DNA minipreparation was done using the restriction enzymes BglII 
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and PacI to ensure the presence of the inserts (Section 3.2.19). Plasmids carrying 
inserts were linearized by restriction digestion using BglII/ PacI. Competent 
NLY2∆TBP1::HIS3 expressing Tbp1p, Tbp1(E186D)p or Tbp1(I143N)p were 
transformed with the linearized plasmids (Section 3.2.13). To confirm if the various 
strains carried the SUA7(E202G) mutation, phenotypic tests and sequencing of the 
genomic DNA were performed to ensure that the strains carried the right mutation. 
   
Table 3.19 Yeast cells with the depicted plasmids used for Microarray analysis. 
 Types of strains  
Strain 1 NLY2::SUA7(WT) TBP1::HIS3 + pYCplac22-TBP1 + pASZ11-GAL4 
Strain 2 NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1 + pASZ11-GAL4 
Strain 3 NLY2::SUA7(WT) TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-GAL4 
Strain 4 NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-GAL4 
Strain 5 NLY2::SUA7(WT) TBP1::HIS3 + pASZ11-TBP1(I143N) + pY1-GAL4 
Strain 6 NLY2::SUA7(E202G) TBP1::HIS3 + pASZ11-TBP1(I143N) + pY1-GAL4 
 
3.2.9.2 Culturing of yeast cells for Microarray Analysis 
Knock-in strains expressing SUA7(E202G)p in the TBP, TBP1(E186D) and 
TBP1(I143N) backgrounds were created as described above. To determine the genes 
affected by various TBP1 mutations that contributed to the slow-growth phenotype, 
cells were pre-cultured at 28°C in glucose medium overnight and diluted 50 X the 
next day. Each sample was harvested between OD600nm= 0.8 to 1.0. 
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3.2.9.3 DNA Microarray 
Microarray experiments were performed with the yeast genome S98 
Affymetrix GeneChip® probe array. The workflow for this experiment is described as 
follows, and detailed protocol of the various experiments mentioned can be found in 
the Affymetrix GeneChip® Expression Analysis technical manual. The major steps in 
performing Microarray analysis are listed below: 
 
Target preparation 
Briefly, total RNA isolation of samples from yeast cells was done using 
RNeasy Mini Kit (QIAGEN; Cat. No.74104). Yeast cells harvested after induction 
were lysed using the beat beater. RNA was quantified, the integrity of the rRNA was 
checked with a spectrophotometer, and the samples were separated on a formaldehyde 
gel. Synthesis of double-stranded cDNA from total RNA was performed using the 
Invitrogen Life Technologies Superscript Choice system and the GeneChip T7-
Oligo(dT) Promoter Primer Kit. The GeneChip® Sample Cleanup Module (QIAGEN; 
900371) was used to clean up the double-stranded cDNA reaction before proceeding 
to the synthesis of biotin-labelled cRNA. Synthesis of biotin-labelled cRNA was done 
using the Enzo BioArray HighYield RNA Transcript Labelling Kit (Affymetrix; P/N 
900182). In the next step, the biotin-labelled cRNA was cleaned up using the 
GeneChip® Sample Cleanup Module (QIAGEN; 900371). The purified cRNA was 
quantified using photometric quantification. Purified cRNA was diluted to 0.6 µg/µl 
before the sample was fragmentated. Fragmentation was carried out using 5X 
fragmentation buffer provided in the cleanup module. 1 µg of the fragmented purified 
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cRNA was loaded onto a formaldehyde gel for electrophoresis to confirm that it had 
been fragmented. 
Target hybridization    
In this process, the fragmented target was hybridised to a test array 
(Micro/Mini Array) before applying the hybridisation cocktail to the standard Yeast 
S98 genechip for analysis. The cocktail included the fragmented target, probe array 
controls, BSA, and herring sperm DNA. Controls include the Control Oligo B2 and 
biotinylated hybridization control. These controls provided signals for the Microarray 
Suite software to perform automatic grid alignment during image analysis and helped 
to determine if the target hybridized to the array and if washing and staining were 
done well. Detailed protocol for this can be found in the GeneChip® Expression 
Analysis Technical Manual. For the yeast genome S98 array, the housekeeping 
control genes were TATA-binding protein, RNA polymerase II and Actin. As long as 
two of these three genes have a 3'/5' signal ratio of less than three, the integrity of 
mRNA of that particular sample was considered to be intact, and fit for hybridization 
to a standard array.   
Probe array washing and staining 
The Fluidius Station 400 was used to wash and stain the probe array. The 
station was operated on a Affymetrix Microarray Suite. Detailed procedure for the 
operation of the fluidius station and Microarray Suite can be found in the GeneChip® 
Expression Analysis Technical Manual. 
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Staining was done using streptavidin phycoerythrin (SAPE). Signal from 
fragmented biotin-labelled target was amplified via anti-streptavidin (goat) and 
biotinylated goat IgG as shown below.  
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Probe array scan and data analysis 
After hybridisation and washing, the array was scanned with a scanner which 
was controlled by the Affymetrix Microarray Suite. Data analysis was done using the 
statistical algorithms implemented in the Affymetrix Microarray Suite Expression 
Analysis version 5.0. 
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Figure 3.2 Summary of workflow to perform Microarray analysis. 
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3.2.10 Analysis of the localization of Ubp3p to GAL1 promoter upon 
galactose induction using chromatin immunoprecipitation  
3.2.10.1 Culturing and cross-linking of samples 
BY4741∆W∆UBP3 + pYCplac22-UBP3 and BY4741∆W∆UBP3 + 
pYCplac22-UBP3-myc9 required for this assay were grown in 50 ml glucose 
selective medium lacking tryptophan. Yeast cells were incubated at 30°C overnight 
with agitation until they reached a turbidity of OD600nm = 1.0. 1.25 ml of 37% 
formaldehyde was added to each culture for cross-linking of proteins to DNA. Cross-
linking was carried out at 30°C with gentle rotation for 20 minutes. After 20 minutes, 
yeast cells were harvested by centrifugation at 3220 x g for 5 minutes. The cell pellets 
were re-suspended and washed with 50 ml distilled water. The cell suspensions were 
centrifuged at 3220 x g for 5 minutes, the water was discarded and the cell pellets 
were re-suspended with 1 ml of water before transferring to an eppendorf tube.  The 
tube was centrifuged for 1 minute at 2940 x g. The water was removed, and the pellets 
were kept at -80°C until needed. This sample was labelled as non-induced. For 
galactose-induction, after growth in glucose medium reached OD600nm = 1.0, cells 
were harvested by centrifugation at 3220 x g for 5 minutes. The supernatants were 
removed, and the cell pellets were re-suspended and washed with 50 ml sterile 
distilled water. The centrifugation step was repeated and the water was removed. 
Galactose-induction was carried out by re-suspending cell pellet in 50 ml galactose 
selective medium. Yeast cells were transferred to a 200ml flask for incubation at 28°C 
for 2 hours with agitation. After 2 hours of induction, yeast cells were subjected to 
formaldehyde cross-linking, washing, and centrifugation as described above.  
                                                                              Chapter 3: Methods and Materials 
 80
3.2.10.2 Cell lysis and sonication 
The cell pellets were re-suspended in 500 ml of ice-cold yeast lysis buffer 
(100 mM Tris pH7.5, 50 mM KCl, 1 mM EDTA, 0.1% NP40). The cell suspension 
was transferred to screw-cap microcentrifuge tube. 2 mM PMSF (Stock = 50 mM) 
was added to the sample. The cap to the tube was screwed tightly, and sealed with 
parafilm. The cells were homogenated via mechanical force using a bead beater. The 
cells were subjected to breaking for 1 minute and rested on ice for the next minute. 
The process was repeated three times.  The cell extracts were harvested through 
spinning at 805 x g for 1 minute using the following method: The top and the bottom 
of the screw-cap tubes were punctuated using 25-G needles. The tubes were 
assembled on top of the flared portion, which was prepared from 5 ml syringes. The 
gadgets were rested on top of 15 ml falcon tubes. The extracts collected were 
transferred to eppendorf tubes and centrifuged at 10140 x g for 25 minutes. The 
supernatants were removed and the cell pellets were re-suspended in 500 ml of yeast 
lysis buffer. Care had to be taken to re-suspend the pellets completely before 
sonication.  
 
To sonicate the samples, the sonicating probe was first cleaned with 70% 
ethanol and then with water before it was inserted halfway into the cell suspension in 
the eppendorf tube. The eppendorf tube was placed on ice in a beaker before 
sonication. The power of sonicator was set to continuous power output of 5%, and the 
duration of sonication was 30 seconds. The sample was rested for the next 30 seconds 
before the next cycle begins. The sonication process was repeated three times. 
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Sonicated samples were centrifuged at 10140 x g for 25 minutes. The supernatants 
were harvested while the pellets were discarded. The sonicated cell lysates were kept 
at -80°C until ready to proceed to the next step.   
 
3.2.10.3 Checking chromatin size and phenol extraction 
To check if the sonicated samples were of desirable fragment size, 100 µl of 
the above samples were used for the reversal of crosslinks. The samples were mixed 
with 10 µl of pronase (20 mg/ml stock) and 90 µl of pronase working solution (0.1 M 
Tris pH 7.5, 0.5% SDS) in a PCR tube. The reaction was incubated for 2 hours at 
42°C, and then for 6 hours at 65°C. After reversal of crosslinks, the samples were 
transferred to eppendorf tubes. The same volume of phenol/chloroform was added 
into the tube and subjected to vortex for 5 minutes. The samples were centrifuged for 
15 minutes at 10140 x g. The aqueous solutions were pipetted to other eppendorf 
tubes, and 1 ml of 100% ethanol was added. The samples were mixed well before 
centrifugation at 10140 x g for 10 minutes. The supernatants were removed and the 
pellets were re-suspended in 200 µl 0.3 M sodium acetate. 1 ml 100% ethanol was 
added. The samples were vortexed briefly before incubation at -20°C for at least 3 
hours. After incubation, the precipitates were centrifuged for 15 minutes at 10140 x g. 
The pellets were washed with 500 µl of 70% ethanol. The samples were centrifuged 
again at 10140 x g for 10 minutes. The pellets were dried in a speedvac for 30 minutes 
before 40 µl sterile distilled water was added. Out of 40 µl, 15 µl was used to check 
fragment sizes on a 2% agarose gel. The rest of the samples were kept at -20°C until 
needed as Input control.    
                                                                              Chapter 3: Methods and Materials 
 82
3.2.10.4 Immunoprecipitation 
200 µl of the extracts were used for immunoprecipitation. 4 µl of anti-myc 
beads were added to each pulldown reaction together with 2 mM PMSF. The extracts 
were incubated with the beads for 2 hours on a rotor at 4°C. After incubation, the 
beads were transferred to Spin-X centrifuge-tube filters, and spun at 614 x g for 2 
minutes.  The beads were washed 4 times with yeast lysis buffer, 4 times with yeast 
lysis buffer with 0.5 M NaCl, 3 times with ChIP wash buffer (10 mM Tris.Cl pH 8.0, 
0.25 M LiCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate), and 3 
times with 1X TE buffer. Each wash was incubated on the rotor at 4°C for 5 minutes 
before spinning down at 614 x g for 2 minutes. Proteins bound to beads were eluted 
using 100 µl of ChIP elution buffer (50 mM Tris.Cl pH 7.5, 10 mM EDTA, 1% SDS) 
by incubation at 65°C for 10 minutes. Reversal of cross-link and precipitation of 
eluted samples were done as stated above, but 20 µl of water was added to dissolve 
the pellets at the end of speedvac.  
 
3.2.10.5 Polymerase Chain Reaction       
For the input, 0.2 µl of sample was used. For immunoprecipitated template, 
0.5 µl was used for the PCR. The PCR products were separated on a 2.5% agarose gel 
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Table 3.20 Reaction mix for PCR. 
Reagent Quantity (µl) 
5X PCR buffer  4 
10 mM dNTPs 0.4 
10 µM GAL1 Forward Primer 0.5 
10 µM GAL1 Reverse Primer 0.5 
25 mM MgCl2 1 
Taq Polymerase 0.1 
RNase-free water 11.4  
Template  0.5 (IP); 0.2 (Input) 
Total Volume 20 µl/ tube 
 
Table 3.21 PCR conditions. 
Step Temperature Time 
1 95°C 10 min 
2 95°C 30 sec 
3 55°C 30 sec 
4 72°C 1 min (back to Step 2; repeat 26 times) 
5 72°C 4 min 
The reaction was carried out for 27 cycles and paused at 4°C upon completion 
 
3.2.11  Analysis of protein stability using cycloheximide 
Yeast cells were grown to OD600nm=1.0 in 12 ml of selective medium. 1 ml 
of cell culture was moved into an eppendorf tube, and referred to as time point 0. The 
sample was centrifuged at 2940 x g for 1 minute. The supernatant was pipetted out 
and discarded. The cell pellet was washed with 1 ml sterile distilled water and 
centrifuged under the same conditions as stated above. Water was pipetted out and the 
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cell pellet was kept at -80°C until needed. To the rest of the cell culture, 100 µl of 
cycloheximide (Sigma) was added (final concentration of 100 µg/ml), and the sample 
was put on a shaker at 30°C. 1 ml of sample was removed at an interval of 20 
minutes, washed with water, and kept at -80°C as above. The cell pellets were used 
for Western blot analysis by re-suspending in 10 µl of 2X loading dye (Section 3.2.7).    
 
3.2.12  Preparation of competent yeast cells  
Yeast cells were made competent using the lithium acetate method. The 
required yeast strain was inoculated into 50 ml YPDA liquid medium and incubated 
overnight at 28ºC with agitation. The cells were harvested in the exponential phase 
(OD600nm = 1.0) by centrifugation at 3220 x g, 20ºC for 5 minutes in a 50 ml 
centrifuge tube. The supernatant was discarded. The cell pellet was re-suspended in 1 
ml of sterile distilled water and transferred to an eppendorf tube for centrifugating at 
2940 x g for 1 minute. The supernatant was discarded, and the cell pellet was re-
suspended in 500µl 0.1M Lithium acetate/TE (pH 7). The cells were made competent 
by incubating at 28ºC for 1 hour. Competent yeast cells could be stored at 4ºC for a 
maximum of two weeks. 
 
3.2.13  Transformation of plasmid into competent yeast cells 
Competent yeast cells were prepared as shown above. The reagents indicated 
below were pipetted in sequence into eppendorf tubes. The reaction tube was vortexed 
to mix the content. Each reaction was incubated for 1 hour at 28°C. After the 
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incubation, the reactions were subjected to heatshock for 15 minutes at 42°C. The 
cells were centrifugated at 2940 x g for 1 minute. The supernatant was removed, and 
the cell pellet was re-suspended in 15-30 µl of sterile distilled water in the flowhood. 
Each sample was streaked onto selection plates, and the candidates were incubated at 
the desirable temperature.  
  
Table 3.22 Reaction mix for plasmid transformation.  
 
 
3.2.14  Yeast breaking  
Each cell pellet was re-suspended in 400 µl of yeast breaking buffer (2% v/v 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8, 1 mM EDTA). 
Approximately 400 µl of glass beads were added to lyse the cells (425-600 µm). To 
each sample, 400 µl of phenol/chloroform 5:1 was added, and the samples were 
subjected to vortexing for 2 minutes. The samples were microcentrifuged at 10140 x g 
for 5 minutes. After spinning, 400 µl of the aqueous phase from each sample was 
pipetted into fresh eppendorf tubes and microcentrifuged at 10140 x g for another 5 
minutes. The supernatants were transferred to fresh eppendorf tubes, and 1 ml of 
100% ethanol was added into each tube. The samples were microcentrifuged at 10140 
Reagent Volume (µl) 
Fish sperm carrier DNA 3                                             
Plasmid                                                                                             1 
Competent Yeast Cells  10 
40% PEG (40% PEG, 100 mM lithium acetate, 1X TE buffer) 80 
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x g for 10 minutes after mixing. The supernatants were discarded, and the pellets were 
washed with 400 µl of 0.3 M sodium acetate and 1 ml of 100% ethanol. Each sample 
was again microcentrifuged at 10140 x g for 10 minutes, and the supernatants were 
removed. The pellets were washed with 700 µl of 70% ethanol, and further 
centrifuged at 2940 x g for 1 minute. The supernatants were discarded, and the pellets 
were dried in a speedvac for 20 minutes. The DNA pellets were dissolved in 100 µl of 
sterile distilled water. The samples were stored at -20°C until needed. 
 
3.2.15  Droplet assay 
Serial dilutions of samples up to 10-5 were performed in 96-well plates. 90 µl 
of sterile distilled water was pipetted into 6 wells horizontally. Cells were picked 
using pipette tips, and mixed into the first well to ensure proper mixing. 10 µl from 
the first well was drawn, and pipetted into the second well. The process was repeated 
until the sixth well was reached where cells had been diluted 10-5 fold. 1-5 µl of each 
dilution was dropped onto selective plates. The plates were incubated at the desired 





























Figure 3.3 Serial dilution done for droplet assay in a 96-well plate. Cells were 
diluted 10-fold until 10-5 fold. Scores were assigned based on cell growth.  
 
3.2.16  Plasmid Ligation 
Ligation was done by pipetting the reagent as listed in sequence (Table 3.23). 
The ligation mix was incubated at 4°C for at least 5 hours. Competent DH5α were 
transformed with the ligated plasmid.  
10 µl  
 Undiluted 10-5 fold 
10-5 fold 0 fold 
Score of 6 
Score of 4 
Selection plate 
Incubation at 28°C 
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Table 3.23 Reaction mix for ligation of plasmid. 
Reagent Quantity (µl) 
Ligation buffer T4 (Boehringer Mannhein, Germany) 1 
Ligase T4 (Boehringer Mannhein, Germany) 0.5 
Vector 1 
Cut fragment 3 
Sterile water 4.5 
  
3.2.17  Plasmid transformation into competent DH5α cells 
DH5α cells were thawed on ice for 5 minutes after removal from -80°C. 30 
µl of competent cells were mixed with the ligation mix. The transformation reaction 
was placed on ice for 20 minutes before being subjected to heatshock for 90 seconds 
at 42°C. 200 µl of LB was added to each transformation reaction after heatshock, and 
the transformation reaction was incubated in 37°C for an hour. After incubation, 25 µl 
of the transformation reaction was plated on a selective LB plate. The plate was 
incubated overnight at 37°C.    
 
3.2.18  Plasmid transformation into competent DH10B cells 
DH10B competent cells were thawed on ice for 5 minutes after removal 
from -80°C. 40 µl of competent cells were mixed with 4 µl of the plasmids in an 
eppendorf tube. The content was transferred into pre-chilled electroporation curvette. 
The samples were electroporated at 1.8 KV. 400 µl of Luria Bertani (LB) was added 
immediately to flush out the cells after electroporation. The cells were pipetted into 
fresh eppendorf tubes and were incubated at 37°C for 1 hour. Individual samples were 
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plated onto selective LB plates. The plates were incubated overnight at 37°C. 
 
3.2.19  DNA Minipreparation 
A single colony was picked from the LB plate, and inoculated into 2 ml of 
LB with chloramphenicol or ampicillin in a culturing tube. The tube was incubated 
with agitation overnight at 37°C. After approximately 16 hours of incubation, the tube 
was removed from the incubator, and the sample from the culturing tube was 
transferred into an eppendorf tube. The sample was centrifuged at 10140 x g for 1 
minute. The supernatant was discarded at the end of the centrifugation, and the pellet 
was re-suspended in 200 µl of DNA Minipreparation solution 1 (Appendix 7.2) 
followed by 200 µl of DNA Minipreparation solution 2 (Appendix 7.2). The content 
was mixed gently before 200 µl of DNA Minipreparation solution 3 (Appendix 7.2) 
was added. The sample was centrifuged at 10140 x g for 10 minutes. After 
centrifugation, the supernatant was transferred into a fresh eppendorf tube. 300 µl of 
isopropanol was pipetted into each eppendorf tube, and the content was mixed well 
before centrifuging at 10140 x g for 10 minutes. The supernatant was removed and 
1 ml of 70% ethanol was added to wash the pellet. The sample was mixed gently and 
further centrifuged at 10140 x g for 5 minutes. The supernatant was removed, and the 
pellet was dried using a speedvac for 20 minutes. The pellet containing the plasmids 
was re-suspended in 50 µl of sterile distilled water. The plasmid was stored at -20˚C 
until needed. 
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3.2.20  Cycle sequencing   
Cycle sequencing of each sample using forward and reverse primers was 
performed. The reagents needed are shown in the table below. The samples were 
subjected to denaturation at 96ºC for 30 seconds, annealing at 50ºC for 15 seconds 
and extension at 60ºC for 4 minutes for 25 cycles. The reaction was held at 4ºC.  
Table 3.24 Cycle sequencing reaction mix of each sample. 
Reagent Volume (µl) 
Terminator Ready Reaction Mix 4 
Template, double-stranded DNA 250ng 
Primer (5' Nub or 3' 1995) 1.6 pmol 
Sterile distilled water 5 
Total reaction volume 10 
           
            
3.2.21  Ethanol precipitation  
After cycle sequencing, samples were transferred to fresh eppendorf tubes. 
80 µl of ethanol/sodium acetate was added to each tube. The tubes were vortexed to 
ensure proper mixing and left in room temperature for 15 minutes. The samples were 
centrifuged at 10140 x g and the supernatants were discarded. 500 µl of 75% ethanol 
was added into each tube and the samples were centrifuged at 10140 x g for 5 minutes. 
The supernatants were removed and the pellets were dried in a speedvac for 10 
minutes. Sequencing was done by the sequencing service team at Department of 
Microbiology, NUS. 
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4 EXPERIMENTAL RESULTS 
4.1 Characterization of the TBP1(E186D) mutation 
4.1.1 Phenotypes displayed by yeast cells carrying the TBP1(E186D) 
mutation 
The transcriptional activators Gal4p and Gcn4p activate the GAL and HIS3 
genes in S. cerevisiae, respectively. Cells lacking GAL4 failed to grow on galactose 
medium in the presence of the respiration inhibitor antimycin A (Figure 4.1a, line 1), 
and cells lacking GCN4 failed to grow on histidine-lacking plates in the presence of 
the competitive inhibitor 3-aminotriazole (Figure 4.1b, line 1). Cells expressing the 
Tbp1(E186D)p mutant in place of wild-type Tbp1p failed to grow on galactose plates 
containing antimycin A (Figure 4.1a, line 3), indicating that Gal4p failed to activate 
the GAL genes. The TBP1(E186D) mutant cells also failed to grow on histidine-
lacking plates containing 3-aminotriazole, indicating that Gcn4p failed to activate the 
HIS3 gene as well (Figure 4.1b, line 3). The TBP1(E186D) mutant cells also 
displayed slow-growth and temperature-sensitivity (Figure 4.1c, line 3). Both Gal4p 
and Gcn4p were able to activate their respective targeted genes in the presence of the 
temperature-sensitive TBP1(I143N) allele (Figure 4.1c, line 4), and the cells were able 
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Figure 4.1 The TBP1(E186D) mutation affected activation by Gal4p and Gcn4p 
and caused temperature-sensitivity. (a) Ten-fold serial dilutions of yeast cells 
expressing the depicted proteins were titrated on glucose and galactose plates 
containing 1 µg/ml antimycin A and incubated on the indicated plates at 28ºC for 10 
days. (b) Ten-fold serial dilutions of yeast cells expressing the depicted proteins were 
titrated on the indicated plates and incubated at 28ºC for 10 days. (c) Ten-fold serial 
dilutions of yeast cells expressing the depicted proteins were titrated on glucose plates 
and incubated at 28°C and 35°C for 10 days. 
 
 
                                                                                     Chapter 4: Experimental Results                       




4.2 Suppression of TBP1(E186D) by SUA7(E202G) 
4.2.1 Screening for suppressors of TBP1(E186D) temperature- 
sensitivity  
We generated libraries of point mutations in Sua7p, Srb4p, Rpb1p, Rpb4p and 
Rpb8p using PCR, and performed suppressor screens in search for mutants that 
allowed yeast cells expressing Tbp1(E186D)p in place of wild-type Tbp1p to grow at 
the restrictive temperature. As the Taq polymerase produces approximately one error 
per 1000 nucleotides under standard conditions, this is sufficient to create single point 
mutation in each gene copy for our studies (Appling, 1999). Figure 4.2 shows that all 
the five genes were successfully amplified by PCR. The PCR fragments were 
recombined into the Nub expression vector via in vivo recombination (gap repair) and 
266 colonies grew at 35°C. Table 4.1 shows the rate of transformation and the number 
of colonies observed at 35°C for each gene. The Nub plasmids in the colonies grown at 
35°C were isolated and tested for plasmid linkage. S. cerevisiae cells expressing 
TBP1(E186D) in place of wild-type TBP1 were transformed with the isolated 
plasmids expressing Nub fusions to the mutant transcription factors. Equal amounts of 
cells were plated onto two different plates and incubated at 28°C and 35°C, 
respectively. The screens resulted in the SUA7 point mutant E202G that allowed the 
TBP1(E186D) mutant to grow at 35°C. The SUA7(E202G) mutant was isolated five 
times independently (Figure 4.3). For the other four Tbp1-interacting proteins affected 
by the TBP1(E186D) mutation, no plasmid-linked suppressor mutant was isolated.  
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Figure 4.2 Electrophoresis of PCR products generated to create point mutation 
in SUA7, SRB4, RPB1-CTD,  RPB4,  RBP8 using pPACNX-Nub- SUA7, -SRB4, -
RPB1, -RPB4, -RBP8 as templates and primers hybridizing to the ADH1 
promoters and terminators, respectively.  
 
Table 4.1 The rate of transformation and the number of colonies observed at 
35°C. The PCR fragments were transformed together with cut vector into 
NYL2∆TBP1::HIS3 + pYCplac22-TBP1(E186D) via gap repair. 0.1% aliquots of 
each transformation mix were plated onto glucose selective medium to check for the 
rate of transformation of each gene into cells.  
 
pPACNX-Nub fusion of 
Gene amplified in PCR 
reaction 
No. of transformants   No. of colonies observed 
at 35°C 
SUA7 76,000 42 
SRB4 83,000 66 
RPB1 70,000 8 
RPB4  89,000 82 
RPB8 64,000 68 
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Figure 4.3 A screen for suppressor of the temperature-sensitivity of TBP1(E186D) 
resulted in the isolation of SUA(E202G) five times independently. Transformants 
were incubated at the permissive temperature (28ºC left) and at the restrictive 
temperature (35°C right), respectively. Five candidates grew at 35°C after 10 days of 
incubation. The candidates were sequenced with 5′Nub and 3′1995 primers. DNA 
sequencing showed that these five candidates carried the same point mutation at 
amino acid position 202, changing glutamic acid to glycine.    
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4.2.2 SUA7(E202G) suppressed all the three phenotypes caused by 
the TBP1(E186D) mutation 
Droplet assays  were performed to semi-quantify the extent of temperature- 
sensitivity suppression and to ask how many of the TBP1(E186D) phenotypes were 
suppressed by the SUA7(E202G) mutation. Figure 4.4 shows that SUA7(E202G) was 
able to partially suppress the temperature-sensitivity phenotype of TBP1(E186D) 
(compare lines 4 and 5). The figure further shows that the SUA7(E202G) mutation 
was allele-specific for the TBP1(E186D) mutation, since SUA7(E202G) did not 
suppress the temperature-sensitive phenotype of TBP1(I143N) (compare lines 6 and 
7). SUA7(E202G) had been isolated from the screen for temperature resistance of 
TBP1(E186D), and we asked if the suppressor was able to suppress the gal- phenotype 
of TBP1(E186D) as well. Figure 4.4 shows that SUA7(E202G) was also able to 
suppress the gal- phenotype of TBP1(E186D). TBP1(E186D) mutants were unable to 
grow on galactose plates in the presence of the respiration inhibitor antimycin A (line 
11). Yeast cells expressing Sua7(E202G)p and Tbp1(E186D)p were able to utilize 
galactose for growth (compare lines 11 and 12). Cells carrying the TBP1(I143N) 
mutation did not display a gal- phenotype and hence the growth was not affected on 
galactose antimycin A plates (line 13).       
 
The TBP1(E186D) mutation had also caused sensitivity to 3-aminotriazole, 
indicating that Gcn4p failed to activate the HIS3 promoter. We asked if the 
SUA7(E202G) mutant was able to suppress this phenotype as well. Figure 4.4 shows 
that SUA7(E202G) was able to restore growth of TBP1(E186D) mutants in the 
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presence of 50 mM 3-aminotriazole (compare lines 17 and 18). This indicated that 
SUA7(E202G) was able to restore transcriptional activation of GAL1 and HIS3 by 
Gal4p and Gcn4p in the TBP1(E186D) mutant background, respectively. 
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Figure 4.4 SUA7(E202G) is an allele-specific suppressor of TBP1(E186D). Ten-
fold serial dilutions of yeast cells expressing the depicted proteins were dropped onto 
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4.2.3 SUA7(E202G) partially restored the transcription level of 
GAL1 mRNA in the TBP1(E186D) background  
The transcription level of GAL1 mRNA in the TBP1 wild-type and 
TBP1(E186D) mutant backgrounds was measured in the presence of SUA7 and 
SUA7(E202G). Total RNA was extracted as shown in the Appendix 7.5 Figure 7.1. 
Both 28S and 18S RNA appeared as sharp bands showing that the integrity of the 
RNA was persevered during the extraction procedure. The quantity, purity, and other 
quality control steps were performed and are shown in the Appendix 7.5. Real-Time 
PCR was performed using SYBR-Green. The relative expression of the GAL1 
transcript in the TBP1 wild-type and TBP1(E186D) mutant backgrounds in the 
presence of SUA7 wild-type and SUA7(E202G) was calculated using the comparative 
threshold (CT) method. Quantitative data are shown in Table 4.2. Numbers shown are 
GAL1 mRNA levels normalized to ACT1 and relative to GAL1 mRNA levels in the 
absence of Gal4p. The experiments were performed in duplicates. 
 
Table 4.2 shows that transcript levels of GAL1 mRNA in galactose were 
reduced some twenty-fold in yeast cells carrying the TBP1(E186D) mutation. 
Transcription of GAL1 in galactose was increased by approximately four-fold in the 
presence of Sua7(E202G)p. This coincides with Figure 4.4, where SUA7(E202G) had 
enabled yeast cells carrying the TBP1(E186D) mutation to grow on galactose plates in 
the presence of antimycin A. 
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Table 4.2 SUA7(E202G) partially restored transcriptional activation of GAL1 by Gal4p in the TBP1(E186D) mutant background. Yeast cells 
expressing the indicated proteins were grown in glucose selective medium (lacking adenine, tryptophan and leucine) to OD600nm=1.0, and induced in 
2% galactose selective medium (lacking adenine, tryptophan and leucine) for 1 hour. Real-time PCR was performed using GAL1 ORF and ACT1 ORF 
primers. Numbers shown are GAL1 mRNA levels normalized to ACT1 and relative to GAL1 mRNA levels in the absence of Gal4p. The experiments 
were performed in duplicates.    
*∆CT was calculated by subtracting the average Actin CT value from individual GAL1 CT value.  
#∆∆CT was calculated by subtracting the ∆CT of the induced sample with the average ∆CT of the induced (-Gal4) sample. 
















29.8 21.65 8.18 Tbp1p 
Sua7p 
Induced in the 




26.64 18.05 8.56 Tbp1(E186D)p 
Sua7p 
Induced in the 




    





0.39 -7.71 209.38 
197.75 +/- 11.63 





0.91 -7.19 146.02 
168.68 +/- 22.66 





5.39 -3.11 8.60 
8.52 +/- 0.09 






3.28 -5.22 37.27 
36.27 +/- 1.01 
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4.2.4 SUA7(E202G) partially restored protein interaction with 
TBP1(E186D) in vivo 
The Split-Ubiquitin assay was used to determine if Sua7(E202G)p was able to 
restore the interaction with Tbp1(E186D)p. Tbp1-Cub-RUra3p and Tbp1(E186D)-Cub-
RUra3p were expressed from single-copy vectors under the control of the CUP1 
promoters. Yeast cells expressing Nub and Tbp1-Cub-RUra3p were able to grow on 
uracil-depleted plates in the absence of CuSO4 (Figure 4.5, line 1). This indicated that 
the fusion of wild-type Tbp1p to Cub-RUra3p was stable and enzymatically active. 
Yeast cells expressing Nub-Sua7p and Tbp1-Cub-RUra3p were unable to grow in the 
absence of uracil (Figure 4.5, line 2). This indicated that Sua7p and Tbp1p interacted 
inside the cell, raising the local concentrations of Nub and Cub (Bongards et al., 2003 
and Virbasius et al., 2001). A native-like ubiquitin was formed and recognized by the 
UBPs. The RUra3 reporter was cleaved off and degraded by the enzymes of the N-
end rule, causing uracil auxotrophy. The figure further shows that Sua7(E202G)p 
interacted with Tbp1p as well (Figure 4.5, line 3).  
 
Yeast cells expressing Tbp1(E186D)-Cub-RUra3p displayed only little growth 
on uracil-depleted plates in the absence of CuSO4 (data not shown). In the presence of 
100 µM CuSO4, however, the yeast cells expressing Tbp1(E186D)-Cub-RUra3p were 
able to grow on the uracil depleted plates to a level comparable to that of yeast cells 
expressing Tbp1-Cub-RUra3p (Figure 4.5, compare lines 1 and 4). This indicated that 
the fusion of the mutant Tbp1(E186D)p to Cub-RUra3p was less stable than the fusion 
of wild-type Tbp1p. Yeast cells expressing Nub-Sua7p and Tbp1(E186D)-Cub-RUra3p 
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were able to grow on uracil-depleted plates in the presence of 100 µM CuSO4 (Figure 
4.5, line 5), indicating that the TBP1(E186D) mutation affected the interaction with 
Sua7p. Yeast cells expressing Tbp1(E186D)-Cub-RUra3p and Nub-Sua7(E202G)p 
were uracil auxotroph in contrast to those expressing  Tbp1(E186D)-Cub-RUra3p and 
Nub-Sua7p. This indicated that the Sua7(E202G)p mutation restored the protein 
interaction with Tbp1(E186D)p (Figure 4.5, compare lines 5 and 6).   
 
 
Figure 4.5 The SUA7(E202G) mutation restored the protein interaction with 
TBP1(E186D) in vivo. Ten-fold serial dilutions of BY4741∆W cells expressing the 
depicted proteins were titrated on the indicated plates and incubated at 39°C for 3 
days. Yeast cells expressing Tbp1(E186D)-Cub-RUra3p were incubated on a uracil-
depleted plate containing 100 µM CuSO4 so that the growth of cells expressing Nub 
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4.2.5 GST-Tbp1p complemented the TBP1 deletion and was used to 
confirm the effects of the mutations on the interaction with 
TFIIB 
To confirm the interaction between Tbp1p and Sua7p in vitro, we 
co-expressed both proteins in yeast cells using different tags. Tbp1p was fused to 
GSTp while Sua7p was fused to Nub and an HA tag. The GST-Tbp1p wild-type and 
mutant fusions were tested if they were able to complement the TBP1 deletion. The 
fusions were transformed into NLY2∆TBP1::HIS3 + pYCplac33-TBP1 together with 
Nub-SUA7 wild-type and E202G. The transformants were titrated onto FOA plates, 
whereby growth on the FOA plates indicated the ability of the fusions to complement 
the TBP1 deletion. Figure 4.6a shows that GST-Tbp1p and GST-Tbp1(I143N)p were 
able to complement the TBP1 deletion (lines 3-4 and 7-8). GST-Tbp1(E186D)p, on 
the other hand, was only able to complement the TBP1 deletion in the presence of 
Nub-Sua7(E202G)p (compare lines 5 and 6). Therefore, we performed the GST-
pulldown experiments, with proteins expressed in JD52 cells, which contain 
endogenous Tbp1p in addition to GST-Tbp1p. Figure 4.6b shows that GST-Tbp1p, 
but not GSTp, was able to precipitate Nub-Sua7p and Nub-Sua7(E202G)p (compare 
lanes 2–5). GST-Tbp1(E186D)p was produced at lower levels than GST-Tbp1p and 
the amount of precipitated Nub-Sua7p was reduced. The co-expression with Nub-
Sua7(E202G)p increased protein levels of GST-Tbp1(E186D)p and precipitation of 
Nub-Sua7(E202G)p was observed (compare lines 6 and 7). GST-Tbp1(I143N)p 
interacted with Nub-Sua7p like GST-Tbp1p, and the interaction was not affected by 
the E202G mutation. Figure 4.6c shows that untagged Tbp1(E186D)p expressed from 
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a single-copy vector under the control of its own promoter was found at lower levels 
than wild-type Tbp1p as well, (compare lanes 1 and 3) and that the Sua7(E202G)p 
suppressor restored the expression level of Tbp1(E186D)p (compare lanes 3 and 4). 
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Figure 4.6 The SUA7(E202G) mutation restored the protein levels of 
TBP1(E186D) (a) Complementation of GST-fusion proteins in the TBP1 deletion 
strain. A yeast strain carrying a chromosomal deletion of TBP1 and expressing TBP1 
from a URA3-marked single-copy vector was transformed with plasmids expressing 
the depicted proteins. Ten-fold serial dilutions of cells were titrated onto glucose 
plates with and without FOA. The plates were incubated at 28°C for 7 days. Growth 
on FOA indicated that the respective GST-Tbp1p fusion was able to complement the 
chromosomal TBP1 deletion. (b) GST-pulldown and Western blot for the analysis of 
the in vitro protein-protein interaction between Sua7(E202G)p and Tbp1(E186D)p. 
Yeast cells expressing the depicted proteins were grown in medium lacking 
tryptophan and leucine, and GST-pulldown assays were performed with cell extracts 
followed by Western blot analysis with anti-GST and anti-HA antibodies. (c) Western 
blot for the analysis of the expression of endogenous Tbp1p and Tbp1(E186D)p. 
Yeast cells expressing the depicted proteins were grown in medium lacking 
tryptophan and leucine, and Western blot analysis was performed with anti-Tbp1p 
antibodies. As loading control, all proteins were visualized with coomassie brilliant 
blue. 
 
4.2.6 Analysis of gene expression in the TBP1(E186D) background in 
the presence of SUA7(E202G) using Microarray Analysis 
We hypothesized that the temperature-sensitivity and slow-growth phenotypes 
observed in the TBP1(E186D) mutant might be due to defects in transcription of 
genes required for growth and survival. To test this hypothesis, we performed a 
genome-wide expression analysis using arrays of oligonucleotides. SUA7(E202G) 
was knocked-into the SUA7 gene of the strain NLY2∆TBP1::HIS3 (Appendix 7.6). 
We compared gene expression in yeast strains carrying the TBP1 wild-type and the 
TBP1(E186D) mutant alleles using the yeast genome S98 array from Affymetrix. This 
array contained approximately 6400 well-characterized genes recognised by SGD 
(Saccharomyces Genome Database) and MIPS (Munich Information Center for 
Protein Sequences) together with around 600 probe sets representing putative opening 
reading, mitochondria proteins, TY proteins (Yeast Retrotransposon), ORFs (Open 
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Reading Frame) from 2 micron plasmids and ORFs from strains other than S288C. Of 
the 7145 genes analyzed, 481 (6.73%) genes were decreased 2-fold or more in cells 
expressing TBP1(E186D) in place of wild-type. Of these 481 genes significantly 
affected by the TBP1(E186D) mutation, 125 were restored back to at least 50% of 
wild-type expression level in the presence of SUA7(E202G), while not being 
significantly affected by the SUA7(E202G) mutation in the TBP1(I143N) background. 
The top ten genes that were sorted out from the data according to the criteria 
mentioned above were listed in Table 4.3. The results of the DNA Microarray 
experiments have been deposited into the ArrayExpress database (accession number 
E-MEXP-1020).  
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Table 4.3 Expression of the rRNA genes was defective in the TBP1(E186D) mutant background and restored by the SUA7(E202G) mutation. 
The genes listed were restored back to at least 50% wild-type expression in the presence of SUA7(E202G) and were not significantly affected in 























1 RDN37-1  -7.1 6.8 -4.8 -0.5 0.2 RDN37-1 35S ribosomal RNA 
2 RDN18-1  -6.3 6.1 -3.8 0 -0.3 RDN18-1 18S ribosomal RNA 
3 RDN25-1  -3.1 2.7 -2.5 0 0.1 RDN25-1 25S ribosomal RNA 
4 TPO3 -3 2.3 0 -0.3 -0.9 
Polyamine transport protein specific for spermine; localizes to the 
plasma membrane; member of the major facilitator superfamily 
5 Ty1 LTR -2.8 2.5 -0.8 0.2 -0.4 YCRWDELTA9 Ty1 LTR 
6 Ty3 LTR -2.7 2.5 -1.1 -0.4 1 YDRWSIGMA4 Ty3 LTR 
7 YIL102C  -2.6 3 -2.4 0.2 1.9 Hypothetical protein 
8 YML122C  -2.6 1.5 -0.3 -0.2 -1.6 
Dubious open reading frame unlikely to encode a protein, based on 
available experimental and comparative sequence data 
9 Ty1 LTR -2.3 1.6 -1.8 -2 -1.1 YCRCDELTA7 Ty1 LTR 
10 HMRA1  -2.3 1.7 0 -0.9 -0.1 
Silenced copy of a1 at HMR; homeobox corepressor that interacts with 
Alpha2p to repress haploid-specific gene transcription in diploid cells 
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Table 4.4 lists several genes of interest for this study that were not affected by 
the TBP1(E186D) and SUA7(E202G) mutations. ADH1 promoter, which had been 
used to express the GST-Tbp1p fusions, as well as CUP1 promoter, which had been 
used to express the Tbp1-CubRUra3p fusions, were left unchanged by the mutations. 
The table further shows that the endogenous TBP1 promoter and the ACT1 gene were 
not affected by the TBP1(E186D) nor the SUA7(E202G) mutations. Hence, the 
decrease in Tbp1p protein level caused by the TBP1(E186D) mutation was probably 
due to a decrease in protein stability, and that the SUA7(E202G) mutation was able to 
suppress the TBP1(E186D) mutation by stabilizing the mutant Tbp1p protein. 
 
Table 4.4 The expression level of ADH1, ACT1, TBP1 and CUP1 was not affected 
by the TBP1(E186D) mutation. The table shows the expression levels in signal 





















1 ADH1 -0.2 0.1 -0.5 0.2 -0.2 
YOL086C Alcohol 
dehydrogenase 
2 ACT1 -0.2 0.2 -0.3 0.1 -0.2 YFL039C Actin 
3 TBP1 -0.1 0.1 0.9 -1.6 -0.2 
YER148W TATA-binding 
protein (TFIID) 
4 CUP1 -0.2 0.1 -0.6 0.2 -0.2 
YHR053C Copper-binding 
metallothionein 
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4.3 Suppression of TBP1(E186D) by over-expression of UBP3 
4.3.1 Over-expression of UBP3 suppressed the gal- phenotype and 3-
aminotriazole-sensitivity of TBP1(E186D) by stabilizing 
Tbp1(E186D)p  
Tbp1(E186D)p was expressed at lower protein levels than wild-type Tbp1p 
even though the TBP1(E186D) mutation did not affect the TBP1 promoter. This 
indicated that the TBP1(E186D) mutation affected the protein stability of Tbp1p. The 
reduced proteolysis stability of Tbp1(E186D)p could be due to its degradation via 
ubiquitin-proteosome dependent proteolysis. Ubp3p is a ubiquitin-specific protease 
that is associated with TFIID (Auty et al., 2004). It has also been reported that the 
deletion of UBP3 caused an accumulation of ubiquitinated proteins in cells (Baxter 
and Craig, 1998). Hence, the over-expression of Ubp3p could be able to stabilize 
Tbp1(E186D)p resulting in the suppression of the phenotypes of TBP1(E186D).    
 
Cycloheximide was used to study the half-life of Tbp1(E186D)p. It is a toxic 
inhibitor of protein biosynthesis in eukaryotes which is produced by Streptomyces 
griseus. Yeast cells producing Tbp1p or Tbp1(E186D)p were treated with 
cycloheximide when culture turbidity reached OD600nm=1.0. Western blot was done to 
determine the amount of Tbp1p detectable over time after the addition of 
cycloheximide. The half-life of Tbp1p and Tbp1(E186D)p were estimated (Appendix 
7.7). Figure 4.7a, shows that wild-type Tbp1p remained stable up to 60 minutes after 
the addition of cycloheximide. In comparison, the half-life of Tbp1(E186D)p was 
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shorter, and stability was found to decline over time as indicated by the fading band 
intensity in Western blot analysis (compare the half-life of Tbp1p with the half-life of 
Tbp1(E186D)p). This further showed that the TBP1(E186D) mutation affected the 
stability of Tbp1p. The UBP3 gene was cloned into a multi-copy plasmid for over-
expression. Figure 4.7a shows that the over-expression of Ubp3p increased the half-
life of Tbp1(E186D)p (compare the half-life of Tbp1(E186D)p with and without the 
over-expression of Ubp3p).  
 
Figure 4.7b shows that yeast cells expressing Tbp1(E186D)p in place of 
Tbp1p displayed a gal- phenotype and 3-aminotriazole-sensitivity. The over-
expression of UBP3 not only suppressed the gal- phenotype of the TBP1(E186D) 
mutation (compare lines 4 and 5), but also the 3-aminotriazole-sensitivity caused by 
this mutation as well (compare lines 8 to 9).  
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Figure 4.7 Over-expression of Ubp3p suppressed the gal- and 3-aminotriazole-
sensitivity phenotypes of TBP1(E186D) because the half-life of Tbp1(E186D)p 
was increased. a) NLY2∆TBP1::HIS3 cells expressing the indicted proteins were 
inoculated into glucose selective medium. Cycloheximide to a final concentration of 
100 µg/ml was added to each culture at OD600nm=1.0. 1 ml sample was collected from 
both cultures before the addition of cycloheximide (time point 0) and every 20 
minutes thereafter. Cell cultures were centrifuged, and cell pellets were analysed with 
Western blot using anti-Tbp1p antibodies. The loading of cell pellet was analysed by 
coomassie staining of the membrane after exposure. b) Ten-fold serial dilutions of 
NLY2∆TBP1::HIS3 cells expressing the depicted proteins were dropped onto the 
indicated plates and incubated at the respective temperature for 10 days. 
Transformants which were carrying empty vector were denoted as + 317.  
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4.3.2 The analysis of protein stability of Tbp1p in UBP3-deleted cells 
To study the effect of endogenous UBP3 on the stability of wild-type Tbp1p, 
Tbp1p was fused to GSTp. Pellets of both wild-type cells and cells deleted for UBP3 
were used for Western blot analysis with anti-GST antibodies. Figure 4.8 shows that 
the amount of GST-Tbp1p diminished considerably in UBP3-deleted cells (compare 
lanes 2 and 4). This indicated that Ubp3p is important for the stability of Tbp1p. The 
deletion of UBP3 did not affect the expression of GST protein, indicating that the 
deletion of UBP3 did not affected transcription of the ADH1 promoter that had been 
used to express GSTp and GST-Tbp1p (compare lines 1 and 3). 
                       
Figure 4.8 Ubp3p is important for the stability of GST-Tbp1p. BY4741∆W and 
BY4741∆W∆UBP3 cells were transformed with GST and GST-Tbp1p. Yeast cells 
were inoculated into glucose selective medium (lacking tryptophan), and were 
harvested when OD600nm=1.0. The cell pellet of each sample was washed and analysed 
with Western blot using anti-GST antibodies.    
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4.3.3 Ubp3p was recruited to the GAL1 promoter upon galactose-
induction  
Ubp3p was expressed under the control of its own promoter from a single-
copy plasmid as a fusion to myc9 in UBP3-deleted cells to investigate if Ubp3p was 
localized to the GAL1 promoter upon galactose-induction using chromatin 
immunoprecipitation. Figure 4.9 showed the PCR products of the input and 
immunoprecipitated samples on an agarose gel, and the graphical representation of the 
chromatin immunoprecipitation results. In glucose, myc9-tagged Ubp3p was not 
found at the GAL1 promoter as tagged and untagged cells gave bands of the same 
intensity (compare lanes 1 and 2). In galactose, the occupancy of myc9-tagged Ubp3p 
at the GAL1 promoter was approximately 8 times higher than that in glucose 
(compare lanes 2 and 4). This indicated that Ubp3p was brought to the promoter of 
GAL1 upon transcription activation. Raw data of the chromatin immunoprecipitation 
assay can be found in Appendix 7.8.  
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Figure 4.9 Ubp3p was localized to GAL1 promoter upon galactose-induction. 
BY4741∆W∆UBP3 + pYCplac22-UBP3 and BY4741∆W∆UBP3 + pYCplac22-
UBP3-myc9 cells were inoculated into selective glucose medium. For non induction 
(in glucose), cells were harvested at OD600nm=1.0. For galactose-induction, cells were 
harvested at OD600nm=1.0, washed, and induced for 2 hours in galactose selective 
medium. PCR was done using GAL1 promoter primers. PCR products were visualised 
using phosphorimager, and the various bands were quantified with densitometry. 
Readings obtained from the PCR products of BY4741∆W∆UBP3 + pYCplac22-
UBP3 cells grown in glucose and galactose were used as background control for 
UBP3-tagged cells grown in glucose and galactose, respectively.  
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4.3.4 Ubp3p was required for galactose-induction of GAL1  
Ubp3p localized to the GAL1 promoter following galactose-induction (Section 
4.3.3). To study the importance of Ubp3p for galactose-induction of the GAL1, We 
measured the transcription level of GAL1 mRNA in the presence and absence of 
Ubp3p. Yeast cells deleted for UBP3 were used. Total RNA was extracted as shown 
in the Appendix 7.9 Figure 7.5. Both 28S and 18S RNA appeared as sharp bands 
showing that the integrity of the RNA was persevered during the extraction 
procedure. The quantity, purity, and other quality control steps were performed and 
are shown in the Appendix 7.9. Real-Time PCR was performed using SYBR-Green. 
Upon galactose-induction, transcription level of GAL1 mRNA in UBP3-deleted cells 
transformed with the empty vector pYCplac22 remained at low level. For UBP3-
deleted cells transformed with the single-copy plasmid pYCplac22-UBP3, GAL1 
transcription level increased approximately 25-fold upon galactose-induction (Figure 
4.10). Table 4.5 shows the calculation of relative expression of GAL1 mRNA. This 
indicated the importance of Ubp3p for galactose-induction of GAL1.  
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Figure 4.10 UBP3p was important for galactose activation of GAL1. 
BY4741∆W∆UBP3 + pYCplac22 and BY4741∆W∆UBP3 + pYCplac22-UBP3 cells 
were inoculated into selective glucose medium. For non induction, cells were 
harvested at OD600nm=1.0. For galactose-induction, cells were harvested at 
OD600nm=1.0, washed, and induced for 2 hours in galactose selective medium. PCR 
was done using GAL1 ORF primers.  
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Table 4.5 Ubp3p was important for galactose-induction of GAL1. BY4741∆W∆UBP3 expressing the indicated proteins were grown in 
glucose selective medium (lacking tryptophan) to OD600nm=1.0, and induced in 2% galactose selective medium (lacking tryptophan) for 2 
hour. Real-time PCR was performed using GAL1 ORF and ACT1 ORF primers. Numbers shown are GAL1 mRNA levels normalized to 
ACT1 and relative to GAL1 mRNA levels in the non-induced samples. The experiments were performed in duplicates. 
*∆CT was calculated by subtracting the average Actin CT value from individual GAL1 CT value.  
#∆∆CT was calculated by subtracting the ∆CT of induced sample with the average ∆CT of non-induced sample. 



































    






6.29 -0.59 1.51 
1.36 +/- 0.15 





2.38 -4.94 30.59 
26.04 +/- 4.56 
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4.3.5 Ubiquitination of Tbp1p 
From the data shown above, Ubp3p was required for transcriptional activation 
of GAL1 by galactose. Ubp3p had the ability to stabilize Tbp1(E186D)p and GST-
Tbp1p was less stable in UBP3-deleted cells. Ubp3p functions in yeast as a ubiquitin-
specific protease, indicating that Tbp1p could be a target of Ubp3p. Hence, Tbp1p 
might be ubiquitinated in vivo. To investigate if Tbp1p was ubiquitinated, yeast cells 
carrying HA-tagged Tbp1p with either untagged ubiquitin or histidine-tagged 
ubiquitin were used. Nickel-bead purification and Western blot analysis were 
performed with cell extracts. Figure 4.11 showed that immunoprecipitation of tagged 
ubiquitin extract revealed a ladder of multiple ubiquitinated Tbp1p species not found 
in the untagged pulldown (compare lanes 3 and 4). In Lane 4, one single major 
species and, perhaps, one or two others were observed. This indicated that Tbp1p was 
ubiquitinated, and that Ubp3p might stabilize Tbp1p by removing this ubiquitin.   
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Figure 4.11 Tbp1p was ubiquitinated in vivo. SUB288∆WL + pYCplac22-HA-
TBP1 + pPactT317-Ub and SUB288∆WL + pYCplac22-HA-TBP1 + pPactT317-
H10-Ub cells were harvested at OD600nm=1.0. Yeast extract were used for nickel-bead 
purification followed by Western Blot analysis with anti-HA antibodies. Lane 1 and 2 
are input of untagged and tagged ubiquitin yeast extract. Lane 3 and 4 are extract (IP) 
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5.1 Suppression of TBP1(E186D) by SUA7(E202G) 
The Split-Ubiquitin system was used to analyze protein-protein interactions 
between Tbp1p and transcription proteins. This system was well-suited for this study 
in comparison to using the classic yeast two-hybrid system, which depends on 
transcriptional read-out. The use of Tbp1p as bait in the conventional yeast two-
hybrid system to screen for protein-protein interactions with transcription proteins 
would have resulted in a high number of false positives. Using this method, wild-type 
Tbp1p were shown to interact with 35 of these proteins (Rpb1p, Rpb3p, Rpb4p, 
Rpb5p, Rpb6p, Rpb8p, Rpb9p, Rpb10p, Toa1p, Tao2p, Sua7p, Taf1p, Taf4p, Taf6p, 
Taf9p, Taf11p, Taf12p, Taf14p, Tfa1p, Tfa2p, Tfg3p, Srb4p, Srb10p, Snf5p, Snf6p, 
Snf11p, Arp7p, Arp9p, Spt8p, Ada2p, H2A, H2B, H4, Nhp6Bp and Rap1p) 
(Bongards et al., 2003). The Split-Ubiquitin system detected spatial proximity 
between these proteins with Tbp1p, but these proteins are not necessarily involved in 
direct interaction with Tbp1p.   
 
In this thesis, we analyzed the protein-protein interactions between Tbp1p and 
other transcription factors by making use of a Tbp1p mutant. This Tbp1p mutant 
carries a point mutation at the amino acid position 186. Tbp1(E186D)p has been 
described previously to cause a severe slow-growth and a gal- phenotype (Virbasius et 
al., 2001). In addition to the reported phenotypic defects, we found that yeast cells 
carrying this mutation also showed sensitivity to 3-aminotriazole and high 
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temperature (Figure 4.1). Out of the 35 proteins found to interact with Tbp1p in the 
Split-Ubiquitin assay, we found that five of these proteins had their interactions 
affected by the TBP1(E186D) mutation. These five proteins are transcription factors 
namely Sua7p (Suppressor of Upstream AUG), Srb4p (Suppressor of RNA 
polymerase B), Rpb1p, Rpb4p and Rpb8p (RNA polymerase B) (Bongards et al., 
2003). 
 
Next, we asked for mutants in these five proteins, which could suppress the 
phenotypes displayed by TBP1(E186D). We used libraries of PCR-generated 
mutations in these five proteins to search for mutants that could suppress the 
temperature-sensitivity of Tbp1(E186D)p. After screening 266 potential candidates 
from the temperature-sensitivity suppressor screen, a Sua7p (TFIIB) mutant carrying 
a substitution at the amino acid position 202 from glutamic acid to glycine was 
isolated (Figure 4.3). SUA7(E202G) was an allele-specific suppressor of the 
temperature-sensitivity of TBP1(E186D). In addition, it also suppressed the gal- 
phenotype and 3-aminotriazole-sensitivity of TBP1(E186D) (Figure 4.4). Both the 
Split-Ubiquitin and GST pulldown assays showed that SUA7(E202G) restored the 
protein interaction between Tbp1p and Sua7p, that had been eliminated by the 
Tbp1(E186D)p mutation (Figure 4.5 and Figure 4.6).  
 
The amino acid E186 is one of the three amino acids bridging Tbp1p to Sua7p 
(Virbasius et al., 2001). Tbp1(E186D)p was found to be capable of binding to the 
TATA-box, but it was not able to support the entry of Sua7p into the preinitiation 
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complex (Virbasius et al., 2001). The inability to support the entry of Sua7p into 
preinitiation complex has detrimenting effects since Sua7p plays multiple roles in 
activated transcription (Chen and Hampsey, 2004; Faitar et al., 2001). As observed, 
Sua7(E202G)p suppressed the gal- phenotype, temperature and 3-aminotriazole 
sensitivity displayed by Tbp1(E186D)p. Hence, one possible mechanism of 
suppression was due to the restoration of a protein-protein interaction lost by the 
primary mutation. This hypothesis was supported by the Split-Ubiquitin assay where 
the interaction between Sua7(E202G)p and Tbp1(E186D)p was restored (Figure 4.5). 
However, through further analysis, the point mutation at Sua7(E202G)p changed the 
glutamic acid residue to a glycine residue. The glycine residue does not have a side-
chain that could account for this restoration. Furthermore, through the study of the 
crystal structure of A. thaliana Tbp1p and human Sua7p (Nikolov et al., 1996), it was 
revealed that the point of mutation in the Sua7p suppressor was not a residue linking 
Sua7p to Tbp1p. Hence, we assume that Sua7(E202G)p might restore the interaction 
to Tbp1(E186D)p via an allosteric manner.    
 
The E186D mutation appeared to affect the protein stability of Tbp1p. This was 
concluded from several observations. Firstly, contrary to wild-type Tbp1p, the 
CubRUra3p fusion of Tbp1(E186D)p expressed from the CUP1 promoter was unable 
to support growth on a plate lacking uracil unless the expression of the fusion was 
increased by the addition of CuSO4. This indicated that the Tbp1(E186D)p fusion was 
less stable (Figure 4.5). Secondly, the protein level of the GST-Tbp1p fusion 
expressed from the ADH1 promoter was also reduced by the E186D mutation, as 
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shown by Western blot analysis with an anti-GST antibody (Figure 4.6b). 
Furthermore, Western blot analysis with an antibody against endogenous Tbp1p 
showed that Tbp1(E186D)p protein levels were significantly reduced as well (Figure 
4.6c). The observations made above were not because of less efficient transcription of 
Tbp1(E186D)p in yeast cells. This was supported from the data we obtained from the 
DNA microarray analysis. The data showed that the mRNA level of CUP1, ADH1, 
and TBP1 were not affected by the E186D mutation (Table 4.4). Therefore, the 
inability of Tbp1(E186D)p to support activated transcription appeared not only to be 
due to the inability to recruit Sua7p into the preinitiation complex, but also due to the 
lack of availability of Tbp1(E186D)p, making Tbp1p the limiting factor of activated 
transcription. The DNA microarray analysis supported this hypothesis as further 
analysis of the data showed that the mRNA level of TBP1(E186D) was not affected 
by the presence of Sua7(E202G)p, while the protein level of Tbp1(E186D)p was 
restored back to Tbp1p wild-type levels (Table 4.4). This indicated that 
Sua7(E202G)p suppressed TBP1(E186D) by stabilizing Tbp1(E186D)p.    
 
We sorted the microarray data to search for genes that were significantly 
affected by the presence of Tbp1(E186D)p, and that were restored by Sua7(E202G)p. 
In comparison, these genes should not be restored by the presence of Tbp1(I143N)p 
and Sua7(E202G)p, since Sua7(E202G)p was found to be an allele-specific 
suppressor of the TBP1(E186D) mutation. The analysis revealed that yeast cells 
carrying the TBP1(E186D) mutation had significantly reduced transcription of 
RDN37-1, RDN18-1 and RDN25-1 (Table 4.3). These ribosomal RNAs are important 
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precursors for the assembly of ribosomal subunits required for protein synthesis of 
vital proteins. Hence, the slow-growth and temperature-sensitivity phenotypes 
observed for the TBP1(E186D) mutation might have been caused by a reduced level 
of proteins or enzymes that are vital for good growth or survival. With the 
stabilization of Tbp1(E186D)p by the presence of Sua7(E202G)p at the promoter, 
transcription of the ribosomal genes was restored back to near wild-type level (Table 
4.3). This facilitated the translation of important proteins and enzymes for survival. 
The suppression of the various phenotypes of the TBP1(E186D) mutation by 
SUA7(E202G) coincided with the restoration of Tbp1(E186D)p expression as 
detected by Western blot (Figure 4.6).   
 
5.2 Suppression of TBP1(E186D) by UBP3 
The stability of Tbp1(E186D)p was compromised due to the E186D mutation. 
The short half-life of Tbp1(E186D)p was thought to be the cause of the gal- 
phenotype and 3-aminotriazole-sensitivity of yeast cells carrying this mutation. In this 
study, we have found that over-expression of Ubp3p in the TBP1(E186D) background 
suppressed, the gal- phenotype and 3-aminotriazole-sensitivity (Figure 4.7b). 
Coincidentally, the over-expression of Ubp3p in the TBP1(E186D) background was 
found to be able to increase the half-life of Tbp1(E186D)p as analyzed using 
cycloheximide (Figure 4.7a). The use of cycloheximide blocks translational 
elongation and prevents protein biosynthesis. Hence, it allows us to study the half-life 
of proteins over time without interference from newly synthesized proteins.  
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The stabilizing effect of Ubp3p was also needed in wild-type Tbp1p as shown 
through the use of UBP3-deleted cells. In UBP3-deleted cells, GST-Tbp1p was found 
to be less stable (Figure 4.8). Additionally, yeast lacking Ubp3p also displayed a gal- 
phenotype. This coincided with the need of Ubp3p to bind to GAL1 promoter upon 
galactose-induction (Figure 4.9). Ubp3p was also found to be indispensable for 
galactose-induction as UBP3-deleted yeast cells could not activate transcription of 
GAL1 properly (Figure 4.10).  
 
Degradation of proteins via the ubiquitin-proteasome pathway is a natural 
process in cells, which helps to get rid of short-lived or abnormal proteins 
(Hatakeyama and Nakayama, 2003; Kuhlbrodt et al., 2005). Ubiquitinated proteins 
are destinated for degradation by the 26S proteasome consisting of the 19S particle 
and 20S proteasome. Ubiquitination of proteins is a reversible change (Baek, 2003). 
The reversal of protein ubiquitination is made possible with the enzymatic effect of 
deubiquitinated enzymes (DUBs), which belong to the UBP (ubiquitin-specific 
protease) family and UCH (ubiquitin carboxy-terminal hydrolases) family. There has 
been a long interest in the regulatory roles of ubiquitination and deubiquitination of 
proteins, especially of transcription factors (Lipford and Deshaies, 2003; Muratani 
and Tansey, 2003). Degradation of transcription factors does not necessarily limit the 
functionality of the target protein. On contrary, degradation could positively regulate 
transcription factors (Muratani et al., 2005; Nalley et al., 2006).   
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UBP3 is a non-essential gene in yeast that is responsible for the cleavage of 
ubiquitin fusions on target proteins. The deletion of UBP3 in cells had been reported 
to cause an accumulation of ubiquitin-protein intermediates (Baxter and Craig, 1998). 
As ubiquitination of proteins causes degradation, the removal of ubiquitin from 
ubiquitinated proteins by Ubp3p could promote protein stability (Brew and Huffaker, 
2002). In this study, we found this to be true for Tbp1p. This came from observations 
with UBP3-deleted yeast cells. Yeast cells lacking UBP3 showed significant 
reduction in the stability of GST-Tbp1p, and they also caused a gal- phenotype 
(Figure 4.8). Tbp1p was found to be polyubiquitinated through nickel-beads pulldown 
assay and Western blot analysis (Figure 4.11). The polyubiquitination of Tbp1p 
would signify the degradation of Tbp1p. Importantly, Ubp3p, which is required for 
deubiquitination and protein stability, was recruited to the GAL1 promoter upon 
galactose-induction, and its presence at the GAL1 promoter was required for 
galactose-induction of GAL1 (Figure 4.9 and Figure 4.10). This makes Tbp1p a 
possible target for Ubp3p, which might help to stabilized Tbp1p during transcriptional 
activation at GAL1 promoter. 
 
Purified TFIID was shown to contain Ubp3p by Buratowski and colleagues 
(Auty et al., 2004). TFIID was purified using a newly developed tag known as HCHH. 
They found that on top of the 14 known TAF proteins and Tbp1p, TFIID was also 
found together with Rsp5p, Bul1p, Ubp3p, Bre5p, Cka1p and Cka2p. Ubp3p and 
Bre5p (BREfeldin A sensitivity) forms a deubiquitination complex. On the other hand, 
Rsp5p (Reverses Spt-Phenotype) together with Bul1p (Binds Ubiquitin Ligase) is an 
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E3 ligase and ubiquitin binding protein, respectively. The functionality of these 
complexes was shown in the ubiquitination pattern of Taf1p and Taf5p, which 
changes with BUL1 or BRE5 deletion. Hence, it is plausible that ubiquitination and 
deubiquitination of Tbp1p could have been regulated by these two complexes upon 
activated transcription.  
 
Tbp1p is a limiting factor for gene activation. The binding of Tbp1p to the 
TATA box is the hallmark of gene activation, as it serves as a platform for the binding 
and recruitment of other transcription factors (Huisinga and Pugh, 2007; Roeder, 
1996). The assembly of transcription factors at the promoter results in the formation 
of the preinitiation complex. Transcription could only occur after the nucleation of the 
preinitiation complex at the promoter. Although Tbp1p was found to be regulated in a 
number of ways (Section 2.5.1.3.1), Tbp1p has not been reported to be ubiquitinated. 
Therefore, with the detection of polyubiquitinated Tbp1p, this could be a novel mode 
of regulating Tbp1p involving its degradation via the ubiquitin-proteasome pathway 
prior to induction. During transcription activation, the stability of Tbp1p is important, 
since it is a limiting factor for transcription, and it is needed as a platform for the 
formation of the preinitiation complex. This idea was supported by the inability of 
unstable Tbp1(E186D)p to activate transcription at the GAL1 promoter and by the 
findings that stabilizing the mutated protein suppressed its phenotypic defects. Here, 
we propose a hypothesis for the regulation of Tbp1p at the promoter, which couples 
deubiquitination with transcription of the GAL genes. Tbp1p could have been 
stabilized by Ubp3-mediated deubiquitination, thereby facilitating activated 
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transcription. In order to support the hypothesis that Tbp1p was indeed 
deubiquitinated at the GAL1 promoter during galactose-induction, mutant yeast strains 
could be used. HUL5 (Hect Ubiquitin Ligase) is a non-essential gene in yeast coding 
for an E4 ubiquitin ligase. HUL5-deleted cells display reduced degradation of 
ubiquitinated proteins (Crosas et al., 2006). Hence, we could use HUL5-deleted cells 
to study ubiquitination of wild-type Tbp1p and Tbp1(E186D)p at the GAL1 promoter 
during galactose-induction. We intend to perform a double chromatin 
immunoprecipitation with anti-Tbp1p antibody and then with anti-Ubiquitin antibody 
to ask for the presence of ubiquitinated Tbp1p at the GAL1 promoter. We planned to 
compare wild-type Tbp1p in cells grown in glucose with wild-type Tbp1p in cells 
grown in galactose, and wild-type Tbp1p with Tbp1(E186D)p in cells grown in 
galactose.     
 
Lysine is the key residue for ubiquitination (Hochstrasser, 2004). Ubiquitin is 
linked by an amide bond formed between its glycine residue at amino acid position 76 
with a lysine residue of the target protein or the preceding ubiquitin. From this study, 
We learnt that Tbp1p is polyubiquitinated. Hence, it will be interesting to find out 
which lysine residues are being ubiquitinated. Therefore, to define which lysine is 
important for the ubiquitination of Tbp1p, we aim to create point mutation at lysine 
residues in Tbp1p that result in Tbp1p mutants, which are stable in UBP3-deleted 
cells. In addition, lysine mutants can also be created in combination with 
Tbp1(E186D)p. We could ask for mutants, which suppress the phenotypes and 
increase the stability of Tbp1(E186D)p. We intended to create lysine mutants using 
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two-step PCR strategy with primers, which will anneal to the site of mutation. These 
primers will carry the intended mutations changing lysine residues to arginine, 
enabling us to create arginine mutation at specific lysine residues.  
 
Based on the results of this thesis, we proposed that stabilization of Tbp1p was 
important for transcriptional activation of the GAL1 promoter upon galactose-
induction. Next, we are interested to find out how long Tbp1p remains stable on the 
TATA-box when cells are subjected to glucose-repression after induction. Would it be 
necessary for Tbp1p on the TATA-box to be ubiquitinated, and be targeted for 
proteolysis for a quick shut down of activated transcription on the GAL1 promoter? 
To answer this question, a fusion of the GAL1 promoter to the URA3 open reading 
frame was integrated into the GAL1 chromosomal locus. Cells carrying this fusion 
were uracil prototroph in galactose medium and uracil auxotroph in glucose medium, 
indicating that galactose-induction had turned the URA3 gene on, while glucose-
repression had turned it off. Over-expression of Ubp3p allowed the cells to grow on 
glucose plates lacking uracil, demonstrating the importance of Tbp1p degradation for 
glucose-repression of GAL1. We intend to use this set up to study the effect of glucose 
shut-down by performing chromatin immunoprecipitation and Real-Time PCR.  
 
The data presented in this study hint at the possibility that Tbp1p is a target of 
Ubp3p. It is conceivable that the stability of Tbp1p is closely linked to Ubp3p, as 
Tbp1p was found to be polyubiquitinated, and deubiquitination by Ubp3p would 
stabilize Tbp1p (Figure 5.1). The stabilization of Tbp1p is perceived to be necessary 
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for the activated transcription of GAL1, and this might also be the case for most 
activated transcription that requires Tbp1p. Degradation of Tbp1p, on the other hand, 
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Figure 5.1 Deubquitination of Tbp1p by Ubp3p during galactose-induction 
stabilizes Tbp1p. In this model, we propose that Tbp1p is ubiquitinated by an E3 
ligase and polyubiquitinated by E4 during glucose-repression. Polyubiquitinated 
Tbp1p attracts the proteasome, which degrades Tbp1p. During galactose-induction, 
ubiquitinated Tbp1p is deubiquinated by Ubp3p at the promoter. This leads to the 
stabilization of Tbp1p at the GAL1 promoter. The presence of Tbp1p at the TATA-
box stimulates the nucleation of the preinitiation complex at the GAL1 promoter 
resulting in activated transcription of GAL1.      
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7 APPENDICES  
7.1 Preparation of culturing plates and broth 
1. Preparation of amino acid premix for 20 L of drop-out medium  
Constituent Premix for 20 L 
Adenine sulphate 0.4 g 
Uracil 0.4 g 
Tryptophan 0.4 g 
Histidine 0.4 g 
Arginine 0.4 g 
Methionine 0.4 g 
Tyrosine 0.6 g 
Leucine 0.6 g 
Isoleucine 0.6 g 
Lysine 0.6 g 
Phenylalanine 1.0 g 
Valine 3.0 g 
Threonine 4.0 g 
Note: For preparation of plates lacking certain amino acids, that particular 
amino acid was left out in the preparation of the premix.  
 
2. Preparation of drop-out medium  
D-Glucose/ D-Galactose  20 g/L 
Yeast nitrogen base     7 g/L 
Amino acid premix   0.7 g/L  
Bacto agar     15 g/L 
Top up to 500 ml  
Top up to 500 ml  
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The bacto agar was autoclaved separately from the other constituents. Upon 
cooling after autoclaving, the agar was mixed with the drop-out medium. 
 
For preparation of drop-out plates with antimycin A:  
To prepare plates containing 0.01, 0.1 or 1 µg/ml of antimycin A, 10 µl, 100 µl 
or 1000 µl of 1 mg/ml stock antimycin A was added to autoclaved agar after 
cooling, respectively.  
 
For preparation of drop-out plates with 3-aminotriazole:  
Stock solution (500 mM) was prepared by dissolving 4.2 g of 3-aminotriazole 
powder in hot sterile water. The stock solution was filter sterilized. To prepare 
plates containing 20 mM or 50 mM 3-aminotriazole, 20 ml or 50 ml of the 
filter sterilized stock solution was added to agar after cooling, respectively. 
 
For preparation of drop-out plates with 5-FOA: 
0.85g of 5-FOA was dissolved in 500 ml glucose premix solution. The 
solution was heated in water bath (~55°C) to dissolve 5-FOA. The premix 
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3. Preparation of YPDA medium 
Yeast extract   10 g/L 
Peptone   20 g/L 
Dextran(Glucose)  20 g/L 
0.003% adenine  40 mg/L 
2% bacto agar   20 g/L 
The constituents were topped up to 1 L with distilled water and autoclaved. 
For preparation of YPDA broth, the agar was left out. 
 
4. Preparation of LB + chloramphenicol/ ampicillin plates 
Tryptone   10 g/L 
Yeast extract   5 g/L 
Sodium chloride  5 g/L 
 
The constituents were topped up to 800 ml with distilled water and 0.2 ml of 
5N NaOH was added to adjust the pH. 15 g/L of bacto agar was added for the 
preparation of plates. To prepare broth, agar was not added. After autoclaving, 
4 ml of 10 mg/L chloramphenicol stock was added to 1 L of LB medium. To 
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7.2 Preparation of DNA minipreparation solutions 
Minipreparation solution I (500 ml) 
50 mM Tris-HCl, pH 7.5/8  25 ml (Stock = 1 M) 
10 mM EDTA    10 ml (Stock = 0.5 M, pH 8) 
10 µg/ml RNase A   0.05 g  
Sterile water    465 ml 
     500 ml 
Note: The constituents were autoclaved. RNase A was added after autoclaving. 
 
Minipreparation solution II (500 ml) 
Sterile water    430 ml 
0.2 M NaOH    20 ml 
1 % SDS    50 ml (Stock = 10%) 
     500 ml 
Note: The solution was not autoclaved. The order of preparation should be followed 
to prevent precipitation. 
 
Minipreparation solution III (500ml) 
Sterile water    500 ml 
1.32 M KAce    65 g 
       500 ml  
                                    Adjust pH to pH 4.8 using 100 % acetic acid 
Note: The constituents were autoclaved after adjusting the pH. 
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7.3 Preparation of SDS-PAGE gel 
Table 7.1 Preparation of 10% and 12% separating gels. 
 10% Separating gel 12% Separating gel 
Water 4 ml 3.3 ml 
30% Bisacrylamide 3.3 ml 4 ml 
Tris HCl (pH 8.8) 2.5 ml 2.5 ml 
10% SDS 100 µl 100 µl 
10% Ammonium persulfate 100 µl 100 µl 
TEMED  4 µl 4 µl 
 
Table 7.2 Preparation of 4% stacking gels. 
 4% Stacking gel 
Water 3 ml 
30% Bisacrylamide 0.65 ml 
Tris HCl (pH 6.8) 1.25 ml 
10% SDS 50 µl 
10% Ammonium persulfate 5 µl 
TEMED  5 µl 
 
7.4 Preparation of buffers for FA gel   
Table 7.3 Composition of 10X FA gel buffer. 
Concentration Chemical 
200 mM 3-[N-morpholino]propanesulfonic acid MOPS 
50 mM Sodium acetate 
10 mM EDTA 
pH to 7.0 with NaOH 
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Table 7.4 Preparation of 1X FA gel running buffer. 
Quantity Chemicals 
100 ml 10X FA gel buffer 
20 ml 37% formaldehyde 
880 ml RNase-free water 
 
 
7.5 SUA7(E202G) partially restored the transcription level of GAL1 
mRNA in the TBP1(E186D) background  
A formaldehyde gel showing the 28S rRNA and 18S rRNA of each sample 
(Table 7.5 and Figure 7.1), quantification of the extracted total RNA using a 
spectrophotomer (Table 7.6) and gel pictures of the PCR products separated on a 
2.5% agarose gel performed using samples after DNase treatment and after RT-PCR 
as templates (Figure 7.2) are shown below. 
Table 7.5 Yeast cells with the depicted plasmids for Real-Time PCR analysis. 
 Strain Plasmids 
1 pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11 
2 pYCplac22-TBP1 + pPACNX-Nub-SUA7 + pASZ11-GAL4 
3 pYCplac22-TBP1 + pPACNX-Nub-SUA7(E202G) + pASZ11-GAL4 
4 pYCplac22-TBP1(E186D) + pPACNX-Nub-SUA7 + pASZ11-GAL4 
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Figure 7.1 The integrity of the 28S and 18S rRNA of samples after RNA 
extraction using RNeasy kit. Samples were separated on a 1.2% formaldehyde gel. 
The lane numbers at the top of the gel picture correspond to the yeast cells with the 
depicted plasmids stated in the above table. The sharp ribosomal bands showed that 
the RNA samples did not suffer major degradation before or during RNA purification. 
 
Table 7.6 Quantification of RNA using a spectrophotometer. An absorbance of 1 
unit at 260 nm corresponds to 40 µg/ml of RNA. The amount of RNA was calculated 
by multiplying readings at OD260nm with 40 µg/ml, dilution factor and 0.05 ml.   
 
 
  Dilution 
factor 
OD260nm OD280nm OD260nm/OD280nm Amount 
(µg) in 
50 µl 
Tbp1 + Sua7p  200 X 0.326 0.170 1.92 130.4 
Tbp1 + Sua7 + Gal4 200 X 0.5 0.241 2.07 200 
Tbp1 + Sua7(E202G) + Gal4 200 X 0.684 0.346 1.98 273.6 
Tbp1(E186D) + Sua7 + Gal4 200 X 0.297 0.147 2.02 118.8 
Tbp1(E186D)+ Sua7(E202G) + Gal4 200 X 0.241 0.131 1.84 96.4 
Tbp1(E186D) + Sua7  200 X 0.160 0.076 2.11 64 
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Figure 7.2 PCR products separated on a 2.5% agarose gel. PCR was performed 
using GAL1 ORF forward and reverse primers. Gel A: PCR preformed using RNA 
samples after DNase treatment as template. The absences of bands showed that 
DNase treatment on total RNA samples were successful. Gel B: PCR preformed using 
cDNA samples after RT-PCR as template. The presence of bands showed that RT-
PCR using DNase treated samples as template were successful. The lane numbers on 
the top of gel pictures correspond to the yeast cells with the depicted plasmids stated 
in Table 7.5. 
 
 
7.6 Analysis of gene expression in the TBP1(E186D) background in 
the presence of SUA7(E202G) using Microarray Analysis 
To check if the knocked-in strategy was successful, the knocked-in candidates 
(Table 7.7) were titrated onto galactose antimycin A plates and on glucose plate for 
incubation at 28°C and 35°C, respectively. In Figure 7.3, knocked-in SUA7(E202G) 
in the presence of Tbp1p did not affect its ability to activate GAL transcription or its 
ability to grow at high temperature (compare line 1 and 2). Knocked-in SUA7(E202G) 
in the TBP1(E186D) background suppressed the gal- phenotype and temperature-
sensitivity of the E186D mutation (compare line 3 and 4). In TBP1(I143N) mutant 
background, knocked-in SUA7(E202G) did not suppress the temperature-sensitivity of 
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TBP1(I143N). This showed that SUA7(E202G) mutation was allele-specific to 
TBP1(E186D) (compare lines 4 and 6). 
 
Table 7.7 Yeast cells with the depicted plasmids used for Microarray analysis. 
 Types of strains  
1 NLY2::SUA7(WT) TBP1::HIS3 + pYCplac22-TBP1 + pASZ11-GAL4 
2 NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1 + pASZ11-GAL4 
3 NLY2::SUA7(WT) TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-GAL4 
4 NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-GAL4 
5 NLY2::SUA7(WT) TBP1::HIS3 + pASZ11-TBP1(I143N) + pY1-GAL4 
6 NLY2::SUA7(E202G) TBP1::HIS3 + pASZ11-TBP1(I143N) + pY1-GAL4 
      
 
Figure 7.3 Yeast cells with knocked-in SUA7(E202G) were able to suppress 
TBP1(E186D) phenotypes. Ten-fold serial dilutions of yeast cells expressing the 
depicted proteins were titrated onto the indicated plates, and incubated at the 
respective temperature for 10 days.  
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7.6.1 Quantification of RNA 
Total RNA of the yeast cells was extracted and the samples were prepared for 
Microarray analysis. A formaldehyde gel showing the 28S and 18S rRNA of each 
sample (Figure 7.4), the quantification of the extracted total RNA (Table 7.8) and 
labeled cRNA using a spectrophotomer (Table 7.9) and the genechip array readings 
(Table 7.10 – Table 7.15 ) are shown below. 
 
             
Figure 7.4 The integrity of the 28S and 18S rRNA of samples after RNA 
extraction using RNeasy kit. Samples were separated on a 1.2% formaldehyde gel. 
The lane numbers on top of the gel pictures correspond to the yeast cells with the 
depicted plasmids in Table 7.7. The sharp ribosomal bands showed that the RNA 
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Table 7.8 Quantification of RNA using a spectrophotometer. An absorbance of 1 
unit at 260 nm corresponds to 40 µg/ml of RNA. The amount of RNA was calculated 
by multiplying readings at OD260nm with 40 µg/ml, dilution factor and 0.05 ml.   
 
 Dilution OD260nm OD280nm OD260nm/OD280nm Amount (µg) 
in 50 µl 
Tbp1p + Sua7p 200 X 0.258 0.149 1.73 103.2 
Tbp1p + Sua7(E202G)p 200 X 0.217 0.126 1.72 86.8 
Tbp1(E186D)p + Sua7p 80 X 0.28 0.17 1.65 44.8  
Tbp1(E186D)p + Sua7(E202G)p 200 X 0.206 0.119 1.73 82.4 
Tbp1(I143N)p + Sua7p 80 X 0.36 0.23 1.57 57.6 
Tbp1(I143N)p + Sua7(E202G)p 80 X 0.48 0.30 1.60 76.8 
 
Table 7.9 Quantification of purified labelled cRNA using a spectrophotometer. 
An absorbance of 1 unit at 260 nm corresponds to 40 µg/ml of RNA. The amount of 
RNA was calculated by multiplying readings at OD260nm with 40 µg/ml, dilution 







 Dilution OD260nm OD280nm OD260nm/OD280nm Amount (µg) 
in 20 µl 
Tbp1p + Sua7p 800X 0.09 0.048 1.875 57.6 
Tbp1p + Sua7(E202G)p 800X 0.085 0.046 1.848 54.4 
Tbp1(E186D)p + Sua7p 800X 0.036 0.018 2.0 23.04 
Tbp1(E186D)p + Sua7(E202G)p 800X 0.048 0.025 1.92 30.72 
Tbp1(I143N)p + Sua7p 800X 0.047 0.023 2.04 30.08 
Tbp1(I143N)p + Sua7(E202G)p 800X 0.058 0.03 1.93 37.12 
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7.6.2 Genechip Array Report 
The array report was generated following the probe array scan and data 
analysis of the genechip. This report showed various form of quality controls to 
validate data obtained from the S98 Affymetrix Genechip. The housekeeping controls 
in the S98 genechip are ACT1 (YFL039C), TBP1(YER148w) and SRB4 (RNA 
polymerase II; YER022w).  At least two of these control genes must have a 3'/5' 
signal ratio of less than three. The spike controls BioB, BioC, BioD and CreX should 
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Table 7.10 S98 Affymetrix Genechip® probe array report for NLY2::SUA7 




Table 7.11 S98 Affymetrix Genechip® probe array report for 
NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1 + pASZ11-GAL4.  
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C 4154 P 4966.4 P 8392.2 P 5837.53 2.02 
AFFX-YER148w 1159.7 P 3604.7 P 2752.4 P 2505.58 2.37 
AFFX-YER022w 23 P 89.9 P 94.3 P 69.07 4.1 
______________________________________________________________________   
          
Spike Controls:         
Probe Set Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 168.7 P 255.7 P 194.2 P 206.19 1.15 
AFFX-BioC 383.9 P     303.4 P 343.66 0.79 
AFFX-BioD 378 P     2254.1 P 1316.05 5.96 
AFFX-Cre  6399.7 P     5638.8 P 6019.24 0.88 
AFFX-Dap  2.1 A 1.4 A 1.8 A 1.79 0.86 
AFFX-Lys  1.8 A 5.5 A 7.7 A 5.02 4.25 
AFFX-Phe  3.6 A 3.2 A 18.2 A 8.34 5.02 
AFFX-Thr  2 A 1.5 A 1.9 A 1.8 0.96 
AFFX-Trp  2.5 A 1 A 0.9 A 1.48 0.37 
 
Housekeeping Controls:        
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C 4807.5 P 5617.2 P 9659.5 P 6694.77 2.01 
AFFX-YER148w 1387.8 P 4470.5 P 2748.5 P 2868.93 1.98 
AFFX-YER022w 31.6 P 66.2 P 101.7 P 66.49 3.22 
______________________________________________________________________   
          
Spike Controls:         
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 160.2 P 240.8 P 214.4 P 205.15 1.34 
AFFX-BioC 346.2 P     330.9 P 338.55 0.96 
AFFX-BioD 424 P     2709.3 P 1566.64 6.39 
AFFX-Cre  7828.3 P     6620 P 7224.15 0.85 
AFFX-Dap  2.2 A 8.9 A 5.5 A 5.52 2.47 
AFFX-Lys  3 A 8.3 A 11.5 A 7.6 3.85 
AFFX-Phe  1.7 A 4.2 A 31 A 12.33 17.76 
AFFX-Thr  2.8 A 10.5 A 1.9 A 5.07 0.68 
AFFX-Trp  1.8 A 1 A 1.2 A 1.36 0.7 
                                                                                                     Chapter 7:  Appendices 




Table 7.12 S98 Affymetrix Genechip® probe array report for NLY2::SUA7 
TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-GAL4.  
 
Table 7.13 S98 Affymetrix Genechip® probe array report for 
NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1(E186D) + pASZ11-
GAL4. 
Housekeeping Controls:        
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C  6804.9 P 6590.2 P 10687.3 P 8027.45 1.57 
AFFX-YER148w  1249.7 P 4011.6 P 2825.4 P 2695.56 2.26 
AFFX-YER022w  24.6 P 67.1 P 99.8 P 63.84 4.06 
______________________________________________________________________   
          
Spike Controls:         
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 163.8 P 260.4 P 167 P 197.1 1.02 
AFFX-BioC 304.8 P     340.9 P 322.83 1.12 
AFFX-BioD 370.8 P     2603.1 P 1486.94 7.02 
AFFX-Cre  4847.6 P     6492.8 P 5670.17 1.34 
AFFX-Dap  0.7 A 4.4 A 0.7 A 1.93 0.91 
AFFX-Lys  0.3 A 5.6 A 4 A 3.29 11.88 
AFFX-Phe  2.6 A 1.6 A 17.2 A 7.17 6.53 
AFFX-Thr  2.5 A 4.7 A 2.1 A 3.09 0.85 
AFFX-Trp  6.8 A 0.7 A 4.4 A 3.97 0.65 
Housekeeping Controls:        
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C  4495.8 P 5321.7 P 9933.8 P 6583.78 2.21 
AFFX-YER148w  1010.7 P 4104.1 P 3036 P 2716.95 3 
AFFX-YER022w  15.9 P 42.9 P 104.6 P 54.48 6.56 
______________________________________________________________________   
          
Spike Controls:         
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 123.6 P 215 P 153.2 P 163.92 1.24 
AFFX-BioC 290.5 P     275.3 P 282.95 0.95 
AFFX-BioD 324 P     2346.7 P 1335.36 7.24 
AFFX-Cre  3903.4 P     4749.8 P 4326.59 1.22 
AFFX-Dap  3.2 A 2.6 A 1.6 A 2.46 0.5 
AFFX-Lys  0.3 A 1.2 A 3.8 A 1.76 12.78 
AFFX-Phe  1.8 A 1.6 A 23.7 A 9.04 13.48 
AFFX-Thr  2.3 A 4 A 4.6 A 3.66 2 
AFFX-Trp  1.5 A 0.6 A 0.6 A 0.93 0.42 
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Table 7.14 S98 Affymetrix Genechip® probe array report for NLY2::SUA7 
TBP1::HIS3 + pYCplac22-TBP1(I143N) + pASZ11-GAL4.  
Housekeeping Controls:        
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C  5656.5 P 5140.2 P 8337 P 6377.89 1.47 
AFFX-YER148w  5348.1 P 9093.4 P 6829.3 P 7090.25 1.28 
AFFX-YER022w  30 P 66.4 P 116.2 P 70.87 3.87 
______________________________________________________________________   
          
Spike Controls:         
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 151.7 P 178.9 P 121.3 P 150.65 0.8 
AFFX-BioC 216.9 P     193.8 P 205.33 0.89 
AFFX-BioD 223.4 P     1839.4 P 1031.38 8.23 
AFFX-Cre  3126.6 P     4151 P 3638.81 1.33 
AFFX-Dap  0.9 A 2.7 A 0.7 A 1.43 0.73 
AFFX-Lys  0.2 A 2.2 A 4.8 2.39 23.59 
AFFX-Phe  2 A 1.4 A 19.3 A 7.56 9.83 
AFFX-Thr  1.5 A 10.8 A 2.5 A 4.89 1.7 
AFFX-Trp  3.7 A 0.5 A 3.6 A 2.6 0.97 
 
 
Table 7.15 S98 Affymetrix Genechip® probe array report for 
NLY2::SUA7(E202G) TBP1::HIS3 + pYCplac22-TBP1(I143N) + pASZ11-GAL4.  
 
Housekeeping Controls:        
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-YFL039C  5678.7 P 5221.2 P 9560.4 P 6820.12 1.68 
AFFX-YER148w  1220.2 P 2803 P 3096.4 P 2373.2 2.54 
AFFX-YER022w  28.6 P 66.2 P 108.1 P 67.63 3.78 
______________________________________________________________________   
          
Spike Controls:         
Probe Set  Sig(5') Det(5') Sig(M') Det(M') Sig(3') Det(3') Sig(all) Sig(3'/5') 
AFFX-BioB 168 P 246.1 P 215.2 P 209.78 1.28 
AFFX-BioC 284.9 P     338.7 P 311.8 1.19 
AFFX-BioD 351.4 P     2532.5 P 1441.93 7.21 
AFFX-Cre  3969 P     5731.9 P 4850.47 1.44 
AFFX-Dap  7.7 A 0.6 A 1.3 A 3.2 0.17 
AFFX-Lys  0.2 A 6.3 A 9.3 A 5.29 39.82 
AFFX-Phe  2 A 1.5 A 25.4 A 9.65 12.96 
AFFX-Thr  1.7 A 3.9 A 3.9 A 3.15 2.23 
AFFX-Trp  6.7 A 0.9 A 0.9 A 2.83 0.14 
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7.7 Over-expression of Ubp3p increased the stability of Tbp1(E186D)p 
Table 7.16 Over-expression of Ubp3p increased the half-life of Tbp1(E186D)p. Individual bands detected from the Western blot 
analysis were quantified. Relative intensity of individual time point was calculated by dividing band intensity with the respective band 
intensity measured at 0 time point. The values were plotted as shown below. Half-life of Tbp1p and Tbp1(E186D)p with and without 
the over-expression of Ubp3p were determined by using the equations (y=mx+c) obtained from each plot. Half-life of each protein (x) 
was calculated by subtracting 0.5 (y) with c and dividing the resulting value with m.        
Time point Tbp1p 
 
Tbp1(E186D)p Tbp1(E186D)p + 181-Ubp3p 
 Band Intensity Relative Intensity Band Intensity Relative Intensity Band Intensity Relative Intensity 
0 25.189 1 17.361 1 60.358 1 
20 16.844 0.669 11.267 0.649 46.499 0.770 
40 19.151 0.760 5.745 0.331 49.145 0.814 
60 14.318 0.568 3.144 0.181 44.83 0.743 
Half-life (min) 71.6 32.8 122.5 
 
Half-life determination of Tbp1p and Tbp1(E186D)p
y = -0.006x + 0.9298
y = -0.0036x + 0.941
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7.8 Ubp3p was recruited to the GAL1 promoter upon galactose-induction 
Table 7.17 Ubp3p was localized to GAL1 promoter upon galactose-induction. PCR was performed using GAL1 promoters. 
PCR products were visualized using phosphorimager and the various bands were quantified with densitometry. The values 
obtained were labelled as signal in the table. The experiments were performed in duplicates.     
 
Signal normalized to 10% input was calculated by dividing Ave signal from IP with Ave signal from Input and multiplying the 
resulting value by 10. Relative standard deviation was calculated by dividing standard deviation with Ave signal from Input and 









Signal normalized to 
10% input  
Relative SD 
Input Glu 22-UBP 9568509.56 6786347.58 8177429 1967285.6 
Input Glu 22-myc-UBP 10757612.37 8982014.47 9869813 1255537.32 
Input Gal 22-UBP 8172993.66 7327890.89 7750442 597577.899 
Input Gal 22-myc-UBP 8628072.79 6904016.13 7766044 1219092.16 
  
IP  Glu 22-UBP 1006059.04 884643.62 945351.3 85853.6668 1.15605 0.104989 
IP  Glu 22-myc-UBP 772872.31 746531.45 759701.9 18625.8007 0.76972 0.018871 
IP Gal 22-UBP 906672.61 790126.13 848399.4 82410.8063 1.09465 0.10633 
IP Gal 22-myc-UBP 4835042.31 4411370.66 4623206 299581.097 5.9531 0.385758 
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7.9 Ubp3p was required for galactose-induction of GAL1 
A formaldehyde gel showing the 28S rRNA and 18S rRNA of each sample 
(Table 7.18 and Figure 7.5), the quantification of the extracted total RNA using a 
spectrophotomer (Table 7.18) and gel pictures of the PCR products separated on a 
2.5% agarose gel performed using samples after DNase treatment and after RT-PCR 
as templates (Figure 7.6) are shown below. 
 
Table 7.18 Quantification of RNA using a spectrophotometer. An absorbance of 1 
unit at 260 nm corresponds to 40 µg/ml of RNA. The amount of RNA was calculated 
by multiplying readings at OD260nm with 40 µg/ml, dilution factor (200X) and 0.05 ml.   
 
 









1.135 0.569 2 454 
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Figure 7.5 The integrity of the 28S and 18S rRNA samples after RNA extraction 
using RNeasy kit. Samples were separated on a 1.2% formaldehyde gel. The lane 
numbers on the top of gel picture correspond to the yeast cells with the depicted 
plasmids stated in the above table. The sharp ribosomal bands showed that the RNA 
samples did not suffer major degradation before or during RNA purification. 
 
            
Figure 7.6 PCR products separated on a 2.5% agarose gel. PCR was performed 
using GAL1 ORF forward and reverse primers. Gel A: PCR preformed using RNA 
samples after DNase treatment as template. The absences of bands showed that 
DNase treatment on total RNA samples were successful. Gel B: PCR preformed using 
cDNA samples after RT-PCR as template. The presence of bands showed that RT-
PCR using DNase treated samples as template were successful. The lane numbers on 
the top of gel pictures correspond to the yeast cells with the depicted plasmids stated 
in Table 7.18. 
